{"content":"<li class=\"n-box-item date-title\" data-end=\"1530244799\" data-start=\"1530158400\" data-txt=\"Monday, December 23, 2019\">Thursday, June 28, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3367066\" data-ts=\"1530230013\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZIOP\" target=\"_blank\">ZIOP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367066-ziopharmplus-1_6-after-enrolling-first-patient-in-glioblastoma-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ziopharm +1.6% after enrolling first patient in glioblastoma study</a></h4><ul>   <li>Ziopharm Oncology (NASDAQ:<a href='https://seekingalpha.com/symbol/ZIOP' title='ZIOPHARM Oncology, Inc.'>ZIOP</a>) is <font color='green'>up 1.6%</font> after hours, adding to the day's gains, after noting it <a href=\"https://seekingalpha.com/pr/17205306-ziopharm-oncology-enrolls-first-patient-phase-1-trial-evaluating-combination-therapy\" target=\"_blank\">enrolled its first patient</a> in a phase 1 clinical trial for combination therapy of controlled IL-12 and Opdivo.</li>    <li>The study will evaluate Ad-RTS-hIL-12 plus veledimex in combination with Opdivo (nivolumab) in adult patients with recurrent glioblastoma ((rGBM)).</li>    <li>&ldquo;By controlling interleukin 12, Ad-RTS-hIL-12 plus veledimex already has shown it can recruit killer T cells into the tumor and increase expression of checkpoints in this microenvironment,\" says Chief Medical Officer Francois Lebel.</li>    <li>Ziopharm expects to enroll up to 18 patients in the study, in multiple leading brain cancer centers in the U.S.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3367066\" data-linked=\"Ziopharm +1.6% after enrolling first patient in glioblastoma study\" data-tweet=\"$ZIOP - Ziopharm +1.6% after enrolling first patient in glioblastoma study https://seekingalpha.com/news/3367066-ziopharmplus-1_6-after-enrolling-first-patient-in-glioblastoma-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3367066-ziopharmplus-1_6-after-enrolling-first-patient-in-glioblastoma-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367065\" data-ts=\"1530228633\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VRTX\" target=\"_blank\">VRTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367065-vertexplus-7_1-rival-galapagos-stumbles-abbvie\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vertex +7.1% as rival Galapagos stumbles with AbbVie</a></h4><ul>   <li>Vertex Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/VRTX' title='Vertex Pharmaceuticals Incorporated'>VRTX</a>) is <font color='green'>up 7.1%</font> after hours following the release of <a href=\"https://seekingalpha.com/news/3367058-galapagos-minus-13-percent-abbvie-pulls-cystic-fibrosis-development-plans\" target=\"_blank\">data from rival Galapagos</a> (NASDAQ:<a href='https://seekingalpha.com/symbol/GLPG' title='Galapagos'>GLPG</a>) that led AbbVie (NYSE:<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a>) to pull out of plans to proceed on triple combination therapy for cystic fibrosis.</li>    <li><a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a> is <font color='red'>down 1.2%</font> after hours; <a href='https://seekingalpha.com/symbol/GLPG' title='Galapagos'>GLPG</a> is <font color='red'>down 12.8%</font>.</li>    <li>Vertex and PTI are working to hustle toward triple combination therapies for the disease.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3367065\" data-linked=\"Vertex +7.1% as rival Galapagos stumbles with AbbVie\" data-tweet=\"$VRTX $VRTX $GLPG - Vertex +7.1% as rival Galapagos stumbles with AbbVie https://seekingalpha.com/news/3367065-vertexplus-7_1-rival-galapagos-stumbles-abbvie?source=tweet\" data-url=\"https://seekingalpha.com/news/3367065-vertexplus-7_1-rival-galapagos-stumbles-abbvie\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367064\" data-ts=\"1530227710\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KBH\" target=\"_blank\">KBH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367064-kb-homeplus-5-after-q2-earnings-top-estimates-amid-strong-housing-market\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KB Home +5% after Q2 earnings top estimates amid strong housing market</a></h4><ul>     <li>KB&nbsp;Home (NYSE:<a href='https://seekingalpha.com/symbol/KBH' title='KB Home'>KBH</a>)&nbsp;<font color='green'>+5.1%</font>&nbsp;after-hours following a strong <a href=\"https://seekingalpha.com/news/3366992-kb-home-beats-0_09-beats-revenue\" target=\"_blank\">Q2 earnings</a> beat and a $10% Y/Y rise in revenue to $1.1B, supported by higher home prices and tighter supply.</li>     <li>KBH also <a href=\"https://www.ft.com/content/0082d354-7b13-11e8-8e67-1e1a0846c475\" target=\"_blank\">outperformed</a> analyst expectations for 2,588 delivery units during the quarter with a 5% Y/Y gain to 2,717, its average selling price climbed 4% to $401.800, and overall operating income jumped 50% to $74M.</li>     <li>Q2 housing gross profit margin gained 170 bps to 17.1% vs. 16.8%-17.2% guidance, and net orders rose 3% to 3,532; ending backlog value grew 3% to $2.24B with the number of homes in backlog increasing 3% to 5,787, the company's highest Q2 backlog value in 11 years.</li>     <li>&ldquo;In the quarter, we produced double-digit revenue growth, expanded our operating margin and significantly improved our profitability, reflecting solid execution on our core business strategy,\"&nbsp;KBH&nbsp;says. \"Moreover, we measurably increased our absorptions per community by 15%.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3367064\" data-linked=\"KB Home +5% after Q2 earnings top estimates amid strong housing market\" data-tweet=\"$KBH - KB Home +5% after Q2 earnings top estimates amid strong housing market https://seekingalpha.com/news/3367064-kb-homeplus-5-after-q2-earnings-top-estimates-amid-strong-housing-market?source=tweet\" data-url=\"https://seekingalpha.com/news/3367064-kb-homeplus-5-after-q2-earnings-top-estimates-amid-strong-housing-market\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367059\" data-ts=\"1530225283\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NKE\" target=\"_blank\">NKE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367059-nikeplus-9-north-america-sales-return-to-growth-beating-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nike +9% as North America sales return to growth, beating estimates</a></h4><ul>     <li>Nike (NYSE:<a href='https://seekingalpha.com/symbol/NKE' title='Nike Inc.'>NKE</a>) <font color='green'>+9.2%</font> after-hours as it posts stronger than expected <a href=\"https://seekingalpha.com/news/3367002-nike-beats-0_05-beats-revenue\" target=\"_blank\">FQ4 earnings</a> and revenues and announces a new $15B buyback program.</li>     <li>&ldquo;Our new innovation is winning with consumers, driving significant momentum in our international geographies and a return to growth in North America,&rdquo; CEO Mark Parker says, as North America sales jumped 2.76%, <a href=\"https://www.reuters.com/article/us-nike-results/nike-returns-to-growth-in-north-america-tops-results-estimates-idUSKBN1JO32T?il=0\" target=\"_blank\">easily beating analyst consensus</a> for a 0.98% increase.</li>     <li>Meanwhile, NKE says its quarterly sales excluding currency changes climbed 10% in Europe, the Middle East and Africa; 25% in Greater China; and 13% in Asia Pacific and Latin America; overall footwear sales  rose 8% and apparel sales surged 15% while equipment sales fell 3%.</li>     <li>Gross margin rose to 44.7% from 44.1% in the prior-year quarter, which NKE says was due primarily to higher average selling prices and its push to sell directly to shoppers.</li>     <li>NKE is <a href=\"https://www.cnbc.com/2018/06/28/nike-sales-top-estimates-as-retailer-sees-return-to-growth-in-us.html\" target=\"_blank\">more upbeat about FY 2019</a>, now seeing revenues rising by a high-single-digit percentage rate, up from a mid-to-high range.</li><li>Among related tickers, <a href='https://seekingalpha.com/symbol/FL' title='Foot Locker, Inc.'>FL</a> <font color='green'>+3.3%</font>, <a href='https://seekingalpha.com/symbol/UA' title='Under Armour, Inc. Class C'>UA</a> <font color='green'>+2.1%</font> after-hours.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3367059\" data-linked=\"Nike +9% as North America sales return to growth, beating estimates\" data-tweet=\"$NKE $NKE $FL - Nike +9% as North America sales return to growth, beating estimates https://seekingalpha.com/news/3367059-nikeplus-9-north-america-sales-return-to-growth-beating-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3367059-nikeplus-9-north-america-sales-return-to-growth-beating-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367058\" data-ts=\"1530223748\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLPG\" target=\"_blank\">GLPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367058-galapagosminus-13-after-abbvie-pulls-out-of-cystic-fibrosis-development-plans\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Galapagos -13% after AbbVie pulls out of cystic fibrosis development plans</a></h4><ul>     <li>Galapagos (NASDAQ:<a href='https://seekingalpha.com/symbol/GLPG' title='Galapagos'>GLPG</a>) <font color='red'>-13.3%</font> after-hours following news that AbbVie (NYSE:<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a>) decided <a href=\"https://globenewswire.com/news-release/2018/06/28/1531388/0/en/Topline-results-of-PELICAN-trial-and-update-on-triple-combo-development-plans.html\" target=\"_blank\">not to proceed</a> with a study of a combination therapy for cystic fibrosis, and GLPG says it is reviewing the future of its collaboration with ABBV.</li>     <li>Galapagos expects the first interim data in Q3 from its FALCON clinical trial with an investigational triple combination therapy comprising potentiator GLPG2451, C1 corrector  GLPG2222 and C2 corrector GLPG2737, but says ABBV would pull out of the previously contemplated second triple combination therapy.</li>     <li>Galapagos also saiys a study of GLPG2737, one of the elements of the potential combination therapy, achieved its primary endpoint.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3367058\" data-linked=\"Galapagos -13% after AbbVie pulls out of cystic fibrosis development plans\" data-tweet=\"$GLPG $GLPG $ABBV - Galapagos -13% after AbbVie pulls out of cystic fibrosis development plans https://seekingalpha.com/news/3367058-galapagosminus-13-after-abbvie-pulls-out-of-cystic-fibrosis-development-plans?source=tweet\" data-url=\"https://seekingalpha.com/news/3367058-galapagosminus-13-after-abbvie-pulls-out-of-cystic-fibrosis-development-plans\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367040\" data-ts=\"1530221389\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GEMP\" target=\"_blank\">GEMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367040-after-hours-gainers-losers-06-28-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (06/28/2018)</a></h4><ul><li><b>Top Gainers:</b> <a href='https://seekingalpha.com/symbol/GEMP' title='Gemphire Therapeutics'>GEMP</a> <font color='green'>+58%</font>. <a href='https://seekingalpha.com/symbol/VRTX' title='Vertex Pharmaceuticals Incorporated'>VRTX</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/NKE' title='Nike Inc.'>NKE</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/HYGS' title='Hydrogenics Corporation'>HYGS</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/BLDP' title='Ballard Power Systems, Inc.'>BLDP</a> <font color='green'>+5%</font>.</li><li><b>Top Losers:</b> <a href='https://seekingalpha.com/symbol/SRV' title='Cushing MLP & Infrastructure Total Return Fund'>SRV</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/AXIM' title='Axim Biotechnologies, Inc.'>OTCQB:AXIM</a> <font color='red'>-5%</font>. <a href='https://seekingalpha.com/symbol/KOPN' title='Kopin Corporation'>KOPN</a> <font color='red'>-3%</font>. <a href='https://seekingalpha.com/symbol/ATUS' title='Altice USA'>ATUS</a> <font color='red'>-3%</font>. <a href='https://seekingalpha.com/symbol/NVT' title='nVent Electric plc'>NVT</a> <font color='red'>-3%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3367040\" data-linked=\"After Hours Gainers / Losers (06/28/2018)\" data-tweet=\"$GEMP $GEMP $VRTX - After Hours Gainers / Losers (06/28/2018) https://seekingalpha.com/news/3367040-after-hours-gainers-losers-06-28-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3367040-after-hours-gainers-losers-06-28-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367033\" data-ts=\"1530220051\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNX\" target=\"_blank\">SNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367033-synnex-acquires-convergys-for-2_43b\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Synnex acquires Convergys for $2.43B</a></h4><ul><li>        Synnex (NYSE:<a href='https://seekingalpha.com/symbol/SNX' title='SYNNEX Corporation'>SNX</a>)<a href=\"https://seekingalpha.com/pr/17205447-synnex-concentrix-division-announces-acquisition-convergys\" target=\"_blank\"> confirms</a> earlier reports that it has acquired Convergys (NYSE:<a href='https://seekingalpha.com/symbol/CVG' title='Convergys Corporation'>CVG</a>) for $2.43B.</li><li>               The deal is for $26.50/share including $13.25/share in cash and 0.1193 Synnex common shares for each Convergys common stock share.&nbsp;</li><li>               Cost synergies expected of $50M in the first year, achieving a minimum of $150M by the third year.&nbsp;</li><li>               Synnex expects non-GAAP EPS accretion of mid-single digits in the first year, up to double-digits by the second year.&nbsp;</li><li>                  Synnex shares are<font color='red'> down 2.9%</font>&nbsp;aftermarket to $103.70.    </li><li>               Convergys shares are<font color='red'> down 0.3</font>% to $25.30.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3366982-convergys-6-percent-report-sale\" target=\"_blank\">Convergys up 6% on report of sale</a> (June 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3367033\" data-linked=\"Synnex acquires Convergys for $2.43B\" data-tweet=\"$SNX $SNX $CVG - Synnex acquires Convergys for $2.43B https://seekingalpha.com/news/3367033-synnex-acquires-convergys-for-2_43b?source=tweet\" data-url=\"https://seekingalpha.com/news/3367033-synnex-acquires-convergys-for-2_43b\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367029\" data-ts=\"1530219368\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CELG\" target=\"_blank\">CELG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367029-acceleronplus-3-on-positive-phase-iii-luspatercept-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acceleron +3% on positive Phase III Luspatercept data</a></h4><ul><li>        Celgene (NASDAQ:<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a>) and Acceleron (NASDAQ:<a href='https://seekingalpha.com/symbol/XLRN' title='Acceleron Pharma Inc.'>XLRN</a>) <a href=\"https://seekingalpha.com/pr/17205399-celgene-acceleron-announce-luspatercept-achieved-primary-key-secondary-endpoints-phase-iii\" target=\"_blank\">announce</a> that Luspatercept achieved primary and key secondary endpoints in Phase III MEDALIST study for low-to-intermediate-risk myelodysplastic syndromes.</li><li>               Primary endpoint was red blood cell transfusion independence of at least 8 consecutive weeks during the first 24 weeks compared to placebo.&nbsp;</li><li>               Secondary endpoints: Improvement in RBC transfusion independence of at least 12 consecutive weeks during the first 24 was the key endpoint. Modified hematologic improvement-erythroid was a meaningful secondary endpoint.&nbsp;</li><li>                  Data from the trial will be submitted to a &ldquo;future medical meeting in 2018.&rdquo;    </li><li>               The companies plan to submit regulatory applications in the US and Europe in 1H19. &nbsp;&nbsp;</li><li>               Celgene shares are&nbsp;<font color='green'>up 0.7%</font>&nbsp;aftermarket to $77.17.&nbsp;</li><li>                  Acceleron Pharma shares are&nbsp;<font color='green'>up 3%</font>&nbsp;to $34.99.&nbsp;&nbsp;&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3367029\" data-linked=\"Acceleron +3% on positive Phase III Luspatercept data\" data-tweet=\"$CELG $CELG $XLRN - Acceleron +3% on positive Phase III Luspatercept data https://seekingalpha.com/news/3367029-acceleronplus-3-on-positive-phase-iii-luspatercept-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3367029-acceleronplus-3-on-positive-phase-iii-luspatercept-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367021\" data-ts=\"1530218495\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/A\" target=\"_blank\">A</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367021-agilent-tech-acquires-prozyme\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Agilent Tech acquires ProZyme</a></h4><ul><li>        Agilent Technologies (NYSE:<a href='https://seekingalpha.com/symbol/A' title='Agilent Technologies Inc.'>A</a>) <a href=\"https://seekingalpha.com/pr/17205357-agilent-technologies-expand-biopharma-consumables-portfolio-acquisition-prozyme\" target=\"_blank\">acquires</a> glycan analysis company ProZyme for undisclosed terms.</li><li>                  The privately-held ProZyme provides glycan analysis reagents, kits, and standards. &nbsp;   </li><li>               Agilent shares are&nbsp;<font color='red'>down 0.2%</font>&nbsp;aftermarket to $61.15.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3367021\" data-linked=\"Agilent Tech acquires ProZyme\" data-tweet=\"$A - Agilent Tech acquires ProZyme https://seekingalpha.com/news/3367021-agilent-tech-acquires-prozyme?source=tweet\" data-url=\"https://seekingalpha.com/news/3367021-agilent-tech-acquires-prozyme\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367020\" data-ts=\"1530218396\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GEMP\" target=\"_blank\">GEMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367020-gemphire-therapeuticsplus-58-after-study-meets-primary-endpoint\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gemphire Therapeutics +58% after study meets primary endpoint</a></h4><ul>     <li>Gemphire Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/GEMP' title='Gemphire Therapeutics'>GEMP</a>) <font color=\"green\">+58.2%</font> after-hours on news its Gemcabene drug candidate <a href=\"https://seekingalpha.com/pr/17205307-gemcabene-meets-primary-endpoint-indigominus-1-study-severe-hypertriglyceridemia-shtg\" target=\"_blank\">met its primary endpoint</a> in an INDIGO-1 study of severe hypertriglyceridemia patients.</li><li>GEMP says median triglycerides significantly decreased by 47% in gemcabene (600 mg) treated patients vs. 27% for placebo-treated patients in the study.</li>     <li>Gemcabene is a first-in-class oral therapy that may be suitable for ~3.5M patients in the U.S. who need to lower their levels of LDL-C or triglycerides to reduce their risk of developing acute pancreatitis.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3367020\" data-linked=\"Gemphire Therapeutics +58% after study meets primary endpoint\" data-tweet=\"$GEMP - Gemphire Therapeutics +58% after study meets primary endpoint https://seekingalpha.com/news/3367020-gemphire-therapeuticsplus-58-after-study-meets-primary-endpoint?source=tweet\" data-url=\"https://seekingalpha.com/news/3367020-gemphire-therapeuticsplus-58-after-study-meets-primary-endpoint\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367010\" data-ts=\"1530217813\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RMBS\" target=\"_blank\">RMBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367010-rambusminus-1_1-on-ceo-termination\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rambus -1.1% on CEO termination</a></h4><ul><li>        Rambus (NASDAQ:<a href='https://seekingalpha.com/symbol/RMBS' title='Rambus, Inc.'>RMBS</a>) <a href=\"https://seekingalpha.com/pr/17205341-rambus-announces-departure-ron-black-chief-executive-officer-luc-seraphin-appointed-interim\" target=\"_blank\">announces</a> the departure of CEO Ron Black effective immediately.</li><li>               The company says Black&rsquo;s termination was unrelated to financial and business performance but instead because his conduct &ldquo;fell short of the Company&rsquo;s standards.&rdquo;&nbsp;</li><li>                  Black also resigned from the board.    </li><li>               Luc Seraphin, SVP &amp; GM of the Memory and Interfaces Division, will serve as interim CEO.&nbsp;</li><li>               Rambus shares are<font color='red'> down 1.1%</font>&nbsp;aftermarket to $12.85.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3367010\" data-linked=\"Rambus -1.1% on CEO termination\" data-tweet=\"$RMBS - Rambus -1.1% on CEO termination https://seekingalpha.com/news/3367010-rambusminus-1_1-on-ceo-termination?source=tweet\" data-url=\"https://seekingalpha.com/news/3367010-rambusminus-1_1-on-ceo-termination\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367002\" data-ts=\"1530217003\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NKE\" target=\"_blank\">NKE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367002-nike-beats-0_05-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nike beats by $0.05, beats on revenue</a></h4><ul><li>Nike (NYSE:<a href='https://seekingalpha.com/symbol/NKE' title='Nike Inc.'>NKE</a>): Q4 EPS of $0.69 <font color='green'>beats by $0.05</font>.</li><li>Revenue of $9.8B (+12.9% Y/Y) <font color='green'>beats by $390M</font>.</li><li>Shares <font color='green'>+3.5%</font>.</li><li><a href='https://seekingalpha.com/pr/17205367-nike-inc-reports-fiscal-2018-fourth-quarter-full-year-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3367002\" data-linked=\"Nike beats by $0.05, beats on revenue\" data-tweet=\"$NKE - Nike beats by $0.05, beats on revenue https://seekingalpha.com/news/3367002-nike-beats-0_05-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3367002-nike-beats-0_05-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366990\" data-ts=\"1530216423\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRVN\" target=\"_blank\">TRVN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366990-trevena-completes-phase-1-study-of-migraine-treatment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trevena completes Phase 1 study of migraine treatment</a></h4><ul><li>Among the findings in the study of TRV250:&nbsp;Dose-related increases in plasma concentrations following subcutaneous administration of doses up to 30 mg, with rapid absorption in the first hour and duration of exposure appropriate for treating acute migraine.</li><li>Subcutaneous doses at and above 9 mg achieved plasma concentrations that were active in preclinical models of migraine.</li><li>Oral bioavailability similar to existing migraine medications, supporting continued development of TRV250 in oral and/or subcutaneous formulations.</li><li>No observed drug-associated EEG changes, consistent with preclinical studies in which TRV250 avoided the seizure liability associated with previous CNS-active delta receptor agonists.</li><li>No clinically significant changes in vital signs, laboratory values, or ECG parameters, and no severe or serious adverse events reported.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17205305-trevena-announces-successful-completion-phase-1-study-trv250-acute-migraine\" target=\"_blank\">Press Release</a></li><li><a href='https://seekingalpha.com/symbol/TRVN' title='Trevena, Inc.'>TRVN</a>&nbsp;<font color='green'>+8%</font>&nbsp;after hours on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366990\" data-linked=\"Trevena completes Phase 1 study of migraine treatment\" data-tweet=\"$TRVN - Trevena completes Phase 1 study of migraine treatment https://seekingalpha.com/news/3366990-trevena-completes-phase-1-study-of-migraine-treatment?source=tweet\" data-url=\"https://seekingalpha.com/news/3366990-trevena-completes-phase-1-study-of-migraine-treatment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366984\" data-ts=\"1530215816\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IBM\" target=\"_blank\">IBM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366984-nomura-initiates-ibm-16-upside-on-cloud-potential\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nomura initiates IBM at 16% upside on cloud potential</a></h4><ul><li>           Nomura Instinet <a href=\"https://www.cnbc.com/2018/06/28/ibm-set-for-sustained-revenue-as-cloud-tech-leads-turnaround.html\" target=\"_blank\">initiates</a> IBM (NYSE:<a href='https://seekingalpha.com/symbol/IBM' title='International Business Machines Corporation'>IBM</a>) with a Buy rating and a $160 price target, a 16% upside to yesterday&rsquo;s close. </li><li> Analyst Jeffrey Kvaal thinks IBM is headed for &ldquo;sustained&rdquo; revenue growth due to cloud and lead sales tech turnarounds. &nbsp; </li><li> IBM shares are&nbsp;<font color='green'>up 1.9%</font>&nbsp;to $140.03.&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3366984\" data-linked=\"Nomura initiates IBM at 16% upside on cloud potential\" data-tweet=\"$IBM - Nomura initiates IBM at 16% upside on cloud potential https://seekingalpha.com/news/3366984-nomura-initiates-ibm-16-upside-on-cloud-potential?source=tweet\" data-url=\"https://seekingalpha.com/news/3366984-nomura-initiates-ibm-16-upside-on-cloud-potential\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366983\" data-ts=\"1530215643\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QURE\" target=\"_blank\">QURE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366983-uniqureplus-13-sorrento-therapeuticsplus-5-b-riley-dbr-starts-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">uniQure +13%, Sorrento Therapeutics +5% as B. Riley DBR starts at Buy</a></h4><ul>     <li>UniQure (<a href='https://seekingalpha.com/symbol/QURE' title='uniQure N.V.'>QURE</a> <font color='green'>+13.1%</font>) shoots higher after B. Riley FBR initiates coverage with a <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/18/06/11952161/3-reasons-why-uniqure-could-overtake-hemophilia-b-virus\" target=\"_blank\">Buy rating</a> and a $50 price target, believing that AMT-061 has the potential to dominate the hemophilia B adeno-associated virus gene therapy space.</li>     <li>In particular, success in a dose confirmation guided to start by the end of Q2, with a readout expected by year-end 2018, potentially could be a key inflection point for QURE shares, the firm says.</li><li>QURE announced earlier today that it has <a href=\"https://seekingalpha.com/pr/17204231-uniqure-enrolls-first-patient-phase-iii-hope-b-pivotal-study-amtminus-061-patients-hemophilia\" target=\"_blank\">enrolled its first patient</a> in a Phase 3 HOPE-B pivotal study  of AMT-061.</li>     <li>The firm also starts Sorrento Therapeutics (<a href='https://seekingalpha.com/symbol/SRNE' title='Sorrento Therapeutics, Inc.'>SRNE</a> <font color='green'>+5.1%</font>) with a <a href=\"https://www.streetinsider.com/Hot+New+Coverage/B.RileyFBR+Starts+Sorrento+Therapeutics+%28SRNE%29+at+Buy/14351507.html\" target=\"_blank\">Buy rating</a> and a $14.25 target, saying SRNE is leveraging its  proprietary technological expertise, which includes one of the world's  most robust fully human monoclonal antibody libraries, to develop novel chimeric antigen receptor T-cell treatments.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366983\" data-linked=\"uniQure +13%, Sorrento Therapeutics +5% as B. Riley DBR starts at Buy\" data-tweet=\"$QURE $QURE $SRNE - uniQure +13%, Sorrento Therapeutics +5% as B. Riley DBR starts at Buy https://seekingalpha.com/news/3366983-uniqureplus-13-sorrento-therapeuticsplus-5-b-riley-dbr-starts-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3366983-uniqureplus-13-sorrento-therapeuticsplus-5-b-riley-dbr-starts-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366982\" data-ts=\"1530215419\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNX\" target=\"_blank\">SNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366982-convergys-up-6-on-report-of-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Convergys up 6% on report of sale</a></h4><ul><li>The rumored Synnex (<a href='https://seekingalpha.com/symbol/SNX' title='SYNNEX Corporation'>SNX</a> <font color='red'>-0.7%</font>) acquisition of Convergys (<a href='https://seekingalpha.com/symbol/CVG' title='Convergys Corporation'>CVG</a> <font color='green'>+5.8%</font>) is close, according to the <em>WSJ</em>, which is reporting a possible deal price of about $26.50 per share, or nearly $2.5B.</li><li>CVG's spike higher brings it to $25.63.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3365073-convergys-plus-4_3-percent-report-potential-sale-synnex\" target=\"_blank\">Convergys +4.3% on report of potential sale to Synnex</a> (June 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3366982\" data-linked=\"Convergys up 6% on report of sale\" data-tweet=\"$SNX $SNX $CVG - Convergys up 6% on report of sale https://seekingalpha.com/news/3366982-convergys-up-6-on-report-of-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3366982-convergys-up-6-on-report-of-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366981\" data-ts=\"1530215035\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRTO\" target=\"_blank\">CRTO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366981-criteo-launches-23m-ai-lab-in-paris\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Criteo launches $23M AI lab in Paris</a></h4><ul><li>        Criteo (NASDAQ:<a href='https://seekingalpha.com/symbol/CRTO' title='Criteo S.A.'>CRTO</a>) is investing $23M in a new AI lab in Paris and plans to hire researchers over the next three years.</li><li>               VP of Research Suju Rajan will lead the lab.&nbsp;</li><li>               The lab could help Criteo diversify its product portfolio beyond retargeting as browsers increasingly offer tracking protection and Europe&rsquo;s new GDPR law requires mandatory pop-ups that let users opt-out of such ads.&nbsp;</li><li>               Criteo shares are&nbsp;<font color='red'>down 2.3%</font>&nbsp;to $32.47.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3366981\" data-linked=\"Criteo launches $23M AI lab in Paris\" data-tweet=\"$CRTO - Criteo launches $23M AI lab in Paris https://seekingalpha.com/news/3366981-criteo-launches-23m-ai-lab-in-paris?source=tweet\" data-url=\"https://seekingalpha.com/news/3366981-criteo-launches-23m-ai-lab-in-paris\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366980\" data-ts=\"1530214725\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DLTR\" target=\"_blank\">DLTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366980-dollar-treeplus-2-credit-suisse-revisits-potential-for-family-dollar-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dollar Tree +2% as Credit Suisse revisits potential for Family Dollar deal</a></h4><ul>     <li>Dollar Tree (<a href='https://seekingalpha.com/symbol/DLTR' title='Dollar Tree, Inc.'>DLTR</a> <font color='green'>+2%</font>) is down 21%&nbsp;YTD but Credit Suisse's Judah Frommer thinks investors should stick with the stock, reiterating an <a href=\"https://www.barrons.com/articles/could-dollar-tree-branch-out-into-m-a-1530199589\" target=\"_blank\">Outperform rating</a> and raising his price target to $99 from $93, saying DLTR could sell the Family Dollar business.</li><li>DLTR has not said it wanted to sell the unit, but Frommer feels the \"perceived ability to  monetize Family Dollar should bolster its valuation,\" along with his  belief that it will see a near-term improvement in operations.</li><li>Dollar General (<a href='https://seekingalpha.com/symbol/DG' title='Dollar General Corporation'>DG</a> <font color='green'>+0.6%</font>) unsuccessfully tried to bid for Family Dollar in 2014, but Frommer still likes the synergies and strategic  rationale for DG to make another try for the business.</li><li>The \"strategic alternatives available to&nbsp;Dollar Tree are becoming  increasingly clear to investors,\" Frommer writes, \"as is the peer-lagging  multiple being placed on the&nbsp;Family Dollar&nbsp;business.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366980\" data-linked=\"Dollar Tree +2% as Credit Suisse revisits potential for Family Dollar deal\" data-tweet=\"$DLTR $DLTR $DG - Dollar Tree +2% as Credit Suisse revisits potential for Family Dollar deal https://seekingalpha.com/news/3366980-dollar-treeplus-2-credit-suisse-revisits-potential-for-family-dollar-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3366980-dollar-treeplus-2-credit-suisse-revisits-potential-for-family-dollar-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366975\" data-ts=\"1530213548\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366975-instagram-stories-hits-400m-daily-users-double-snapchat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Instagram Stories hits 400M daily users, double Snapchat</a></h4><ul><li>           Instagram (<a href='https://seekingalpha.com/symbol/FB' title='Facebook'>FB</a> <font color='green'>+0.6%</font>) Stories now have <a href=\"https://www.cnbc.com/2018/06/28/instagram-stories-daily-active-users-double-snapchats.html\" target=\"_blank\">400M daily users</a> compared to Snapchat&rsquo;s (<a href='https://seekingalpha.com/symbol/SNAP' title='Snap Inc.'>SNAP</a> <font color='green'>+4.1%</font>) 191M, according to new Instagram data and Snap&rsquo;s Q1 report, respectively. </li><li> Instagram&rsquo;s latest update to Stories lets users add background music. </li><li> The Soundtrack feature will roll out to iOS users in the US, UK, Australia, New Zealand, France, Germany, and Sweden with a global roll-out coming &ldquo;in the future.&rdquo; </li><li> Instagram will offer a library of &ldquo;thousands of songs&rdquo; for Soundtrack.&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3366552-report-snap-preparing-gaming-platform-fall\" target=\"_blank\">Report: Snap preparing gaming platform for fall</a> (June 27)</li></ul><div class=\"tiny-share-widget\" data-id=\"3366975\" data-linked=\"Instagram Stories hits 400M daily users, double Snapchat\" data-tweet=\"$FB $FB $SNAP - Instagram Stories hits 400M daily users, double Snapchat https://seekingalpha.com/news/3366975-instagram-stories-hits-400m-daily-users-double-snapchat?source=tweet\" data-url=\"https://seekingalpha.com/news/3366975-instagram-stories-hits-400m-daily-users-double-snapchat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366970\" data-ts=\"1530212438\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VVPR\" target=\"_blank\">VVPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366970-technology-top-5-gainers-losers-of-3-00-pm-06-28-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3:00 PM (06/28/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/VVPR' title='VivoPower International PLC'>VVPR</a> <font color='green'>+46%</font>. <a href='https://seekingalpha.com/symbol/NIHD' title='NII Holdings, Inc.'>NIHD</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/PRGS' title='Progress Software Corporation'>PRGS</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/AWRE' title='Aware, Inc.'>AWRE</a> <font color='green'>+15%</font>. CAVM <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ABIL' title='Ability Inc.'>ABIL</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/LINK' title='Interlink Electronics'>LINK</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/IZEA' title='IZEA Worldwide, Inc.'>IZEA</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/SMTX' title='SMTC Corporation'>SMTX</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/FTR' title='Frontier Communications Corporation'>FTR</a> <font color='red'>-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366970\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3:00 PM (06/28/2018)\" data-tweet=\"$VVPR $VVPR $NIHD - Technology - Top 5 Gainers / Losers as of 3:00 PM (06/28/2018) https://seekingalpha.com/news/3366970-technology-top-5-gainers-losers-of-3-00-pm-06-28-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3366970-technology-top-5-gainers-losers-of-3-00-pm-06-28-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366967\" data-ts=\"1530212115\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOX\" target=\"_blank\">FOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366967-fox-shareholder-urges-hearing-out-comcast-counter-offer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fox shareholder urges hearing out Comcast counter-offer</a></h4><ul>   <li>One big shareholder in Twenty-First Century Fox (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a> <font color='green'>+2.1%</font>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color='green'>+2%</font>) is urging Rupert Murdoch to give Comcast (<a href=\"http://seekingalpha.com/symbol/CMCSA\" target=\"_blank\">CMCSA</a> <font color='green'>+1%</font>) a chance.</li>    <li>With Fox seemingly barreling toward closing a $71.3B agreement to sell its media assets to Disney (<a href=\"http://seekingalpha.com/symbol/DIS\" target=\"_blank\">DIS</a> <font color='green'>+0.9%</font>), TCI Fund Management <a href=\"https://www.reuters.com/article/us-fox-m-a-activist/fox-shareholder-urges-murdoch-to-give-comcast-time-to-beat-disney-bid-idUSKBN1JO2TB?il=0\" target=\"_blank\">wants to hear another counter-offer</a>, Reuters reports.</li>    <li>The hedge fund owns 7.4% of Fox shares and is \"strongly motivated\" to support whichever deal comes at the biggest price.</li>    <li>That means disagreeing with Murdoch's stance that Comcast's offers, which until this latest one have been superior in absolute value, would come with higher regulatory risk.</li>    <li>The Justice Dept. has <a href=\"https://seekingalpha.com/news/3366625-justice-dept-signs-disneys-71b-fox-deal\" target=\"_blank\">already signed off on Disney's agreement</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366967\" data-linked=\"Fox shareholder urges hearing out Comcast counter-offer\" data-tweet=\"$FOX $FOX $FOXA - Fox shareholder urges hearing out Comcast counter-offer https://seekingalpha.com/news/3366967-fox-shareholder-urges-hearing-out-comcast-counter-offer?source=tweet\" data-url=\"https://seekingalpha.com/news/3366967-fox-shareholder-urges-hearing-out-comcast-counter-offer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366964\" data-ts=\"1530211147\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NIHD\" target=\"_blank\">NIHD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366964-nii-holdingsplus-14-on-report-of-nextel-brazil-sale-plans\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NII Holdings +14% on report of Nextel Brazil sale plans</a></h4><ul>   <li>NII Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/NIHD' title='NII Holdings, Inc.'>NIHD</a>) has <font color='green'>jumped 14.1%</font> after a Reuters report that says the company's hired advisers to <a href=\"https://www.reuters.com/article/nii-holdings-divestiture-brazil/nii-holdings-puts-nextel-brazil-up-for-sale-sources-idUSL1N1TT2C6\" target=\"_blank\">sell its Nextel operations in Brazil</a>.</li>    <li>The company's hired Rothschild to help it unload a 70% stake.</li>    <li>Potential buyers include Telefonica Brasil (<a href='https://seekingalpha.com/symbol/VIV' title='Telefonica Brasil, S.A'>VIV</a> <font color='green'>+1.2%</font>) and Access Industries, which holds another 30% stake (which might be included in a forced sale if Access doesn't buy it all).</li>    <li>Nextel Brazil has 3M subscribers but poor earnings.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366964\" data-linked=\"NII Holdings +14% on report of Nextel Brazil sale plans\" data-tweet=\"$NIHD $NIHD $VIV - NII Holdings +14% on report of Nextel Brazil sale plans https://seekingalpha.com/news/3366964-nii-holdingsplus-14-on-report-of-nextel-brazil-sale-plans?source=tweet\" data-url=\"https://seekingalpha.com/news/3366964-nii-holdingsplus-14-on-report-of-nextel-brazil-sale-plans\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366962\" data-ts=\"1530210724\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VG\" target=\"_blank\">VG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366962-vonage-two-year-high-william-blair-bullish\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vonage at two-year high with William Blair bullish</a></h4><ul>   <li>Vonage Holdings (NYSE:<a href='https://seekingalpha.com/symbol/VG' title='Vonage Holdings Corp.'>VG</a>) has risen to a two-year high, <font color='green'>up 3.6%</font>, after a note from William Blair looks toward upcoming multiple expansion.</li>    <li>There's a \"couple of turns\" of opportunity there and the company could \"rerate to a revenue multiple sometime in 2019,\" says analyst Dmitry Netis. M&amp;A should play a big part in the company's strategy, he says. (h/t Bloomberg)</li>    <li>Netis has an Outperform rating on shares, joining more than a half-dozen other analysts.</li>    <li>Shares have <font color='green'>gained 20.9%</font> YTD and are <font color='green'>up 85%</font> over the past 12 months.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366962\" data-linked=\"Vonage at two-year high with William Blair bullish\" data-tweet=\"$VG - Vonage at two-year high with William Blair bullish https://seekingalpha.com/news/3366962-vonage-two-year-high-william-blair-bullish?source=tweet\" data-url=\"https://seekingalpha.com/news/3366962-vonage-two-year-high-william-blair-bullish\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366957\" data-ts=\"1530209262\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EROS\" target=\"_blank\">EROS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366957-eros-now-partners-sri-lankan-provider\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eros Now partners with Sri Lankan provider</a></h4><ul>   <li>Eros International (<a href=\"http://seekingalpha.com/symbol/EROS\" target=\"_blank\">EROS</a> <font color='red'>-1.8%</font>) has partnered with a <a href=\"https://seekingalpha.com/pr/17204785-dialog-partners-eros-now-give-sri-lankans-best-regional-content\" target=\"_blank\">Sri Lankan connectivity provider</a> to add its Eros Now streaming service.</li>    <li>The Bollywood-focused film producer has a deal with Dialog Axiata to bring Eros Now to the Dialog ViU app, which has about 1M users.</li>    <li>Users will subscribe for a monthly fee of 100 rupees (about $1.45).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366957\" data-linked=\"Eros Now partners with Sri Lankan provider\" data-tweet=\"$EROS - Eros Now partners with Sri Lankan provider https://seekingalpha.com/news/3366957-eros-now-partners-sri-lankan-provider?source=tweet\" data-url=\"https://seekingalpha.com/news/3366957-eros-now-partners-sri-lankan-provider\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366956\" data-ts=\"1530209250\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366956-big-day-for-mexican-peso-ahead-of-elections\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Big day for Mexican peso ahead of elections</a></h4><ul><li>A victory for&nbsp;Andres Manuel Lopez Obrador&rsquo;s Morena party and even frostier relations between Mexico and the U.S. are already priced in, says Wells Fargo's Erik Nelson.</li><li>But consider the possibility that Lopez Obrador fails to secure a congressional majority, says Nelson. The peso, he suggests could quickly strengthen to 19 per dollar, and eventually rise to 17.50.</li><li>A worst-case scenario - a victory by Lopez Obrador and majorities in both houses of congress - could send the peso down to 21 per greenback.</li><li>Source: Bloomberg</li><li>The peso today is&nbsp;<font color='green'>u</font>p more than 2%, helping the iShares MSCI Mexico Capped ETF (<a href='https://seekingalpha.com/symbol/EWW' title='iShares MSCI Mexico Capped ETF'>EWW</a> <font color='green'>+2.9%</font>) to a big gain.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/EWW' title='iShares MSCI Mexico Capped ETF'>EWW</a>, <a href='https://seekingalpha.com/symbol/MXF' title='Mexico Fund'>MXF</a>, <a href='https://seekingalpha.com/symbol/MXE' title='Mexico Equity&Income Fund'>MXE</a>, <a href='https://seekingalpha.com/symbol/DBMX' title='Deutsche X-trackers MSCI Mexico Hedged Equity ETF'>DBMX</a>, <a href='https://seekingalpha.com/symbol/HEWW' title='iShares Currency Hedged MSCI Mexico ETF'>HEWW</a>, <a href='https://seekingalpha.com/symbol/MEXX' title='Direxion Daily MSCI Mexico Bull 3X ETF'>MEXX</a>, <a href='https://seekingalpha.com/symbol/FLMX' title='Franklin FTSE Mexico ETF'>FLMX</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3366956\" data-linked=\"Big day for Mexican peso ahead of elections\" data-tweet=\"$EWW $MXF $MXE - Big day for Mexican peso ahead of elections https://seekingalpha.com/news/3366956-big-day-for-mexican-peso-ahead-of-elections?source=tweet\" data-url=\"https://seekingalpha.com/news/3366956-big-day-for-mexican-peso-ahead-of-elections\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366953\" data-ts=\"1530208845\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBR\" target=\"_blank\">GBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366953-energy-materials-top-5-gainers-losers-of-2-00-pm-06-28-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (06/28/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/GBR' title='New Concept Energy, Inc.'>GBR</a> <font color='green'>+35%</font>. <a href='https://seekingalpha.com/symbol/BRN' title='Barnwell Industries, Inc'>BRN</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/RPM' title='RPM International Inc.'>RPM</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/UUUU' title='Energy Fuels Inc'>UUUU</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/SBGL' title='Sibanye-Stillwater'>SBGL</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/PFIE' title='Profire Energy, Inc.'>PFIE</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/GEVO' title='Gevo, Inc.'>GEVO</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/PED' title='PEDEVCO Corp.'>PED</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/GPRE' title='Green Plains Inc.'>GPRE</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/WOR' title='Worthington Industries, Inc.'>WOR</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366953\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (06/28/2018)\" data-tweet=\"$GBR $GBR $BRN - Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (06/28/2018) https://seekingalpha.com/news/3366953-energy-materials-top-5-gainers-losers-of-2-00-pm-06-28-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3366953-energy-materials-top-5-gainers-losers-of-2-00-pm-06-28-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366950\" data-ts=\"1530208131\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WELL\" target=\"_blank\">WELL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366950-welltower-brookdale-senior-living-on-move-after-restructuring-relationship\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Welltower, Brookdale Senior Living on the move after restructuring relationship</a></h4><ul><li>Welltower (NYSE:<a href='https://seekingalpha.com/symbol/WELL' title='Welltower Inc.'>WELL</a>)<font color='green'> rises 3.2%&nbsp;</font>and Brookdale Senior Living&nbsp;<font color='green'>gains 2.4%</font>&nbsp;the day after they announced a plan that reduces Welltower's reliance on Brookdale. The announcement came after close of trading yesterday.</li><li>Welltower agreed to early termination of Brookdale's triple-net lease obligations on 37 communities.</li><li>Brookdale is also getting out of a joint venture with Welltower, which will take on a new partner--recently formed Pegasus Senior Living.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3366713-welltower-starts-new-ridea-joint-venture-pegasus-senior-living\" target=\"_blank\">Welltower starts new RIDEA joint venture with Pegasus Senior Living</a> (June 27)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3366693-brookdale-senior-early-lease-termination-pact-welltower-sell-jv-stake\" target=\"_blank\">Brookdale Senior in early lease termination pact with Welltower, to sell JV stake</a> (June 27)</li></ul><div class=\"tiny-share-widget\" data-id=\"3366950\" data-linked=\"Welltower, Brookdale Senior Living on the move after restructuring relationship\" data-tweet=\"$WELL - Welltower, Brookdale Senior Living on the move after restructuring relationship https://seekingalpha.com/news/3366950-welltower-brookdale-senior-living-on-move-after-restructuring-relationship?source=tweet\" data-url=\"https://seekingalpha.com/news/3366950-welltower-brookdale-senior-living-on-move-after-restructuring-relationship\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366944\" data-ts=\"1530207564\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OMN\" target=\"_blank\">OMN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366944-on-omnova-solutions-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on OMNOVA Solutions Q2 results</a></h4><div><ul><li>OMNOVA Solutions (<a href='https://seekingalpha.com/symbol/OMN' title='OMNOVA Solutions Inc.'>OMN</a> <font color='green'>+1.3%</font>) reported Q2 net sales decrease of 6.8% Y/Y to $206.3M due to decline in sales of Performance materials segment.</li><li>Specialty solutions results: Sales $128.8M (+6% Y/Y) driven by 2.4% Y/Y increase in volumes and favorable forex of 3.7%. Adj. Operating margin&nbsp;<font color='green'>improved by 276 bps</font>&nbsp;to 17% and Adj. EBITDA margin i<font color='green'>mproved by 289 bps</font>&nbsp;to 20.4%</li><li>Performance materials results: Sales $77.5M (-22.34% Y/Y) volumes were down 10.9%, due to declining sales into the commodity paper market. Adj. Operating margin<font color='green'> recovered by 799 bps</font>&nbsp;to 0.8% and Adj. EBITDA margin&nbsp;<font color='red'>declined by 247 bps</font>&nbsp;to 4.6%.</li><li>Q2 Overall margins: Gross&nbsp;<font color='green'>improved by 97 bps</font>&nbsp;to 25% and Adj. EBITDA&nbsp;<font color='green'>improved by 146 bps</font>&nbsp;to 11.6%.</li><li>SG&amp;A expenses decreased 8.9% Y/Y to $27.4M.</li><li>Net Debt to Adjusted EBITDA improved to 3.0x from 3.6x.</li><li>Company announced the closure of its&nbsp;Green Bay, Wisconsin&nbsp;high volume styrene butadiene production facility and expects $7-8M in annualized savings.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3366811-omnova-solutions-beats-0_01-beats-revenue\" target=\"_blank\">Omnova Solutions beats by $0.01, beats on revenue</a> (June 28)</li></ul></div><div class=\"tiny-share-widget\" data-id=\"3366944\" data-linked=\"More on OMNOVA Solutions Q2 results\" data-tweet=\"$OMN - More on OMNOVA Solutions Q2 results https://seekingalpha.com/news/3366944-on-omnova-solutions-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3366944-on-omnova-solutions-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366946\" data-ts=\"1530207534\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWTR\" target=\"_blank\">TWTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366946-twitter-shuffles-structure-centralizes-engineering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Twitter shuffles structure, centralizes engineering</a></h4><ul>   <li>Twitter (<a href=\"http://seekingalpha.com/symbol/TWTR\" target=\"_blank\">TWTR</a> <font color='green'>+1.6%</font>) is shuffling leadership to a \"more straightforward\" management structure, according to <a href=\"https://twitter.com/jack/status/1012381283396157440\" target=\"_blank\">memos</a> just posted by CEO Jack Dorsey.</li>    <li>\"Through the lens of increasing our durability, agility, invention and entrepreneurial drive, and simplifying the way we work, I've decided to make our organization more straightforward,\" Dorsey writes. \"We are moving back to a functional organization.\"</li>    <li>\"All of engineering will move to Mike Montano. Bluebird Product including Curation will move to Kayvon [Bekypour]. Revenue Product including the DES and MoPub product and business teams will continue to be led by Bruce [Falck]. User Services will move to Matt [Derella], broadening his customer focus.\"</li>    <li>The company's been operating under a general manager structure for a while, he notes, but it's \"not a true GM structure in the full sense of being full-stack.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366946\" data-linked=\"Twitter shuffles structure, centralizes engineering\" data-tweet=\"$TWTR - Twitter shuffles structure, centralizes engineering https://seekingalpha.com/news/3366946-twitter-shuffles-structure-centralizes-engineering?source=tweet\" data-url=\"https://seekingalpha.com/news/3366946-twitter-shuffles-structure-centralizes-engineering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366942\" data-ts=\"1530206459\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVM\" target=\"_blank\">CVM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366942-cel-sciminus-4_9-on-5m-registered-direct-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cel-Sci -4.9% on $5M registered direct offering</a></h4><ul><li>           Cel-Sci (NYSEMKT:<a href='https://seekingalpha.com/symbol/CVM' title='Cel-Sci Corporation'>CVM</a>) <a href=\"https://seekingalpha.com/pr/17205138-cel-sci-announces-5-million-registered-direct-offering\" target=\"_blank\">announces</a> a $5M registered direct offering with institutional investors. </li><li> In connection, Cel-Sci will issue about 3.9M registered shares of common stock at a $1.30/share purchase price. </li><li>           Cel-Sci shares are&nbsp;<font color='red'>down 4.9%</font>&nbsp;to $1.57. <br />&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3366942\" data-linked=\"Cel-Sci -4.9% on $5M registered direct offering\" data-tweet=\"$CVM - Cel-Sci -4.9% on $5M registered direct offering https://seekingalpha.com/news/3366942-cel-sciminus-4_9-on-5m-registered-direct-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3366942-cel-sciminus-4_9-on-5m-registered-direct-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366936\" data-ts=\"1530205393\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SJR\" target=\"_blank\">SJR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366936-shaw-communications-down-3_7-post-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shaw Communications down 3.7% post Q3 results</a></h4><ul><li>Shaw Communications (<a href='https://seekingalpha.com/symbol/SJR' title='Shaw Communications Inc.'>SJR</a> <font color='red'>-3.7%</font>) <a href=\"https://seekingalpha.com/filing/4081839\" target=\"_blank\">reports Q3</a> revenue growth of 6.9% Y/Y to C$1.3B.</li><li>Subscribers: Wireline of 5.74M (-1.2% Y/Y); Wireless of 1.32M (+14.8% Y/Y) &amp; Total of 7.05M (+1.3% Y/Y).</li><li>Continued momentum in Wireless including strong customer demand for Big Gig data plans resulted in 27% Y/Y increase in service revenue and over 54,000 postpaid Wireless subscriber.</li><li>Operating margin&nbsp;<font color='green'>increased marginally 10 bps</font>&nbsp;to 42.1%; for Wireline&nbsp;<font color='green'>increased 150 bps</font>&nbsp;to 45.6% &amp; for Wireless&nbsp;<font color='red'>declined 110 bps</font>&nbsp;to 26.2%.</li><li>Net debt leverage ratio of 2.0x &amp; Free cash flow of C$191M (+44.7% Y/Y).</li><li>Capex of C$293M, a decline of C$7M in Wireline capital spending, primarily due to lower success-based capital, was offset by increased spending in Wireless of C$10M as the Company continues to invest in its network, including spectrum deployment.</li><li>When combined with existing corporate and dealer store network, Freedom Mobile expects to have ~600 retail locations operational in early 2019.</li><li>The Company is currently focused on building out its 700 MHz spectrum, which will continue throughout fiscal 2019.</li><li><strong>2018 Outlook:</strong> Consolidated operating income of ~C$2.1B; capital investments of ~C$1.38B; and free cash flow of ~C$375M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3366802-shaw-communications-reports-q3-results\" target=\"_blank\">Shaw Communications reports Q3 results</a> (June 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3366936\" data-linked=\"Shaw Communications down 3.7% post Q3 results\" data-tweet=\"$SJR - Shaw Communications down 3.7% post Q3 results https://seekingalpha.com/news/3366936-shaw-communications-down-3_7-post-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3366936-shaw-communications-down-3_7-post-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366937\" data-ts=\"1530205256\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLDC\" target=\"_blank\">CLDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366937-financials-top-gainers-losers-of-1-00-pm-06-28-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top Gainers / Losers as of 1:00 PM (06/28/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CLDC' title='China Lending Corporation'>CLDC</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/BFR' title='BBVA Banco Francés S.A.  ADR'>BFR</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/RILY' title='B. Riley Financial, Inc.'>RILY</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/TRMT' title='Tremont Mortgage Trust'>TRMT</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/LYL' title='Dragon Victory International Limited'>LYL</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/HGSH' title='China HGS Real Estate, Inc.'>HGSH</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366937\" data-linked=\"Financials - Top Gainers / Losers as of 1:00 PM (06/28/2018)\" data-tweet=\"$CLDC $CLDC $BBAR - Financials - Top Gainers / Losers as of 1:00 PM (06/28/2018) https://seekingalpha.com/news/3366937-financials-top-gainers-losers-of-1-00-pm-06-28-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3366937-financials-top-gainers-losers-of-1-00-pm-06-28-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366934\" data-ts=\"1530204809\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBR\" target=\"_blank\">GBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366934-midday-gainers-losers-06-28-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (06/28/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/GBR' title='New Concept Energy, Inc.'>GBR</a> <font color='green'>+83%</font>. <a href='https://seekingalpha.com/symbol/PRGS' title='Progress Software Corporation'>PRGS</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/PED' title='PEDEVCO Corp.'>PED</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/BRN' title='Barnwell Industries, Inc'>BRN</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/VVPR' title='VivoPower International PLC'>VVPR</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/APOG' title='Apogee Enterprises, Inc.'>APOG</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/USEG' title='U.S. Energy Corp.'>USEG</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/CLDC' title='China Lending Corporation'>CLDC</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/MSG' title='The Madison Square Garden Company'>MSG</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/STAF' title='Staffing 360 Solutions, Inc.'>STAF</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ASNS' title='Arsanis, Inc.'>ASNS</a> <font color='red'>-75%</font>. <a href='https://seekingalpha.com/symbol/DFBG-OLD' title='Differential Brands Group Inc.'>DFBG-OLD</a> <font color='red'>-32%</font>. <a href='https://seekingalpha.com/symbol/KERX' title='Keryx Biopharmaceuticals, Inc.'>KERX</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/CADC' title='China Advanced Construction Materials Group, Inc.'>CADC</a> <font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/AKBA' title='Akebia Therapeutics, Inc.'>AKBA</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/GMS' title='Gypsum Management and Supply'>GMS</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/ABIL' title='Ability Inc.'>ABIL</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/PIR' title='Pier 1 Imports Inc.'>PIR</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/HEI.A' title='HEICO Corporation'>HEI.A</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/XELB' title='Xcel Brands, Inc.'>XELB</a> <font color='red'>-20%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366934\" data-linked=\"Midday Gainers / Losers (06/28/2018)\" data-tweet=\"$GBR $GBR $PRGS - Midday Gainers / Losers (06/28/2018) https://seekingalpha.com/news/3366934-midday-gainers-losers-06-28-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3366934-midday-gainers-losers-06-28-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:53 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366935\" data-ts=\"1530204458\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WBA\" target=\"_blank\">WBA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366935-baml-cuts-walgreens-to-underperform-shares-down-10-on-session\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BAML cuts Walgreens to Underperform; shares down 10% on session</a></h4><ul><li>An earnings beat, guidance boost, $10B buyback plan, and increase in dividend aren't coming close to outweighing Amazon's entry into drug distribution. Walgreens (NASDAQ:<a href='https://seekingalpha.com/symbol/WBA' title='Walgreens Boots Alliance, Inc.'>WBA</a>) is&nbsp;<font color='red'>lower by nearly 10%</font>.</li><li>BAML's Michael Cherny expects pressure on the stock to stick, noting headwinds like pressure on core script growth, slower front-of-store growth, and now the Amazon threat.</li><li>He downgrades to Underperform from Neutral, with price target of $60 about matching the current price.</li><li>Source: Bloomberg</li><li>Previously: <a href=\"https://seekingalpha.com/news/3366833-pharmacy-drug-distributor-stocks-fall-amazons-pillpack-acquisition\" target=\"_blank\">Pharmacy, drug distributor stocks fall on Amazon's PillPack acquisition</a> (June 28)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3366795-walgreens-boots-alliance-boosts-lower-end-year-adj-eps-guidance-range\" target=\"_blank\">Walgreens Boots Alliance boosts lower end of year adj. EPS guidance range</a> (June 28)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3366779-walgreens-boots-alliance-authorizes-10b-share-repurchase-program-increases-quarterly-dividend\" target=\"_blank\">Walgreens Boots Alliance authorizes $10B share repurchase program and increases quarterly dividend</a> (June 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3366935\" data-linked=\"BAML cuts Walgreens to Underperform; shares down 10% on session\" data-tweet=\"$WBA - BAML cuts Walgreens to Underperform; shares down 10% on session https://seekingalpha.com/news/3366935-baml-cuts-walgreens-to-underperform-shares-down-10-on-session?source=tweet\" data-url=\"https://seekingalpha.com/news/3366935-baml-cuts-walgreens-to-underperform-shares-down-10-on-session\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>49&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366931\" data-ts=\"1530203156\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TBIO\" target=\"_blank\">TBIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366931-translate-bio-opens-9_7-below-ipo-price\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Translate Bio opens about 9.7% below IPO price</a></h4><ul>   <li>Shares in Translate Bio (NASDAQ:<a href='https://seekingalpha.com/symbol/TBIO' title='Translate Bio'>TBIO</a>) opened for trading at $11.50, below <a href=\"https://seekingalpha.com/news/3366728-translate-bio-prices-upsized-initial-public-offering\" target=\"_blank\">last night's IPO pricing</a> of $13/share.</li>    <li>They're currently floating around $11.74, about a <font color='red'>9.7% decline</font>.</li>    <li>The company priced at the midpoint of its range, but with the offering upsized from previous plans to 9.35M shares.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366931\" data-linked=\"Translate Bio opens about 9.7% below IPO price\" data-tweet=\"$TBIO - Translate Bio opens about 9.7% below IPO price https://seekingalpha.com/news/3366931-translate-bio-opens-9_7-below-ipo-price?source=tweet\" data-url=\"https://seekingalpha.com/news/3366931-translate-bio-opens-9_7-below-ipo-price\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366927\" data-ts=\"1530202401\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RAMP\" target=\"_blank\">RAMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366927-acxiomplus-3_5-1_5b-bids-seen-for-data-unit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acxiom +3.5% with $1.5B bids seen for data unit</a></h4><ul>   <li>Shares in Acxiom (NYSE:<a href='https://seekingalpha.com/symbol/ACXM' title='LiveRamp Holdings, Inc.'>ACXM</a>) are jumping, <font color='green'>up 3.5%</font>, after a <i>WSJ</i> report expecting <a href=\"https://www.wsj.com/articles/ad-giants-expected-to-bid-over-1-5-billion-for-acxioms-customer-data-business-1530201685?mod=hp_major_pos14\" target=\"_blank\">bids of $1.5B-plus</a> from ad giants for the company's data-marketing unit.</li>    <li>That's most of Acxiom, which has a market cap of $2.3B. Data marketing made up about three-quarters of total revenue in fiscal 2018.</li>    <li>Bids are expected from Interpublic Group (NYSE:<a href='https://seekingalpha.com/symbol/IPG' title='Interpublic Group of Companies Inc.'>IPG</a>) and Dentsu (<a href='https://seekingalpha.com/symbol/DNTUY' title='Dentsu Inc. ADR'>OTCPK:DNTUY</a>) among others ahead of a deadline today, according to the report.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366927\" data-linked=\"Acxiom +3.5% with $1.5B bids seen for data unit\" data-tweet=\"$RAMP $RAMP $IPG - Acxiom +3.5% with $1.5B bids seen for data unit https://seekingalpha.com/news/3366927-acxiomplus-3_5-1_5b-bids-seen-for-data-unit?source=tweet\" data-url=\"https://seekingalpha.com/news/3366927-acxiomplus-3_5-1_5b-bids-seen-for-data-unit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366923\" data-ts=\"1530202129\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRNE\" target=\"_blank\">SRNE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366923-sorrento-therapeuticsplus-2_2-b-riley-starts-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sorrento Therapeutics +2.2% as B. Riley starts at Buy</a></h4><ul>   <li>Sorrento Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SRNE' title='Sorrento Therapeutics, Inc.'>SRNE</a>) is <font color='green'>up 2.2%</font> after a start at Buy by B. Riley, on the strength of a solid pipeline and recent strategic moves, including a partnership with Celularity.</li>    <li>The firm's Andrew D'Silva has a price target of $14.25, more than double current price of $6.95.</li>    <li>Sorrento shares are <font color='green'>up 79%</font> YTD and have <font color='green'>gained 232%</font> over the past 12 months.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366923\" data-linked=\"Sorrento Therapeutics +2.2% as B. Riley starts at Buy\" data-tweet=\"$SRNE - Sorrento Therapeutics +2.2% as B. Riley starts at Buy https://seekingalpha.com/news/3366923-sorrento-therapeuticsplus-2_2-b-riley-starts-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3366923-sorrento-therapeuticsplus-2_2-b-riley-starts-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366922\" data-ts=\"1530201909\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LEA\" target=\"_blank\">LEA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366922-trade-tensions-whack-auto-names\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trade tensions whack auto names</a></h4><ul><li>The major indexes are in the green, but the Russell 3000 Auto Part Index is now&nbsp;<font color='red'>lower by more than 3%</font>&nbsp;over the last two sessions. The president continues to threaten tariffs on German auto imports, and Osram has&nbsp;<font color='red'>plunged more than 20%&nbsp;</font>in Frankfurt after cutting forecasts, in part thanks to trade issues.</li><li>Bloomberg's&nbsp;Clelia Imperiali notes there are few possibilities for governments to cushion the impact, with company supply chains becoming ever more international.</li><li>Lear (<a href='https://seekingalpha.com/symbol/LEA' title='Lear Corporation'>LEA</a> <font color='red'>-4%</font>), Visteon (<a href='https://seekingalpha.com/symbol/VC' title='Visteon Corporation'>VC</a> <font color='red'>-3.7%</font>), American Axle (<a href='https://seekingalpha.com/symbol/AXL' title='American Axle & Manufacturing Holdings, Inc.'>AXL</a> <font color='red'>-2.9%</font>), Danaher (<a href='https://seekingalpha.com/symbol/DAN' title='Dana, Inc.'>DAN</a> <font color='red'>-2.6%</font>), Gentherm (<a href='https://seekingalpha.com/symbol/THRM' title='Gentherm Incorporated'>THRM</a> <font color='red'>-0.9%</font>), Tenneco (<a href='https://seekingalpha.com/symbol/TEN' title='Tenneco Inc.'>TEN</a> <font color='red'>-2.5%</font>), Cooper-Standard (<a href='https://seekingalpha.com/symbol/CPS' title='Cooper-Standard Holdings Inc.'>CPS</a> <font color='red'>-1.7%</font>), BorgWarner (<a href='https://seekingalpha.com/symbol/BWA' title='BorgWarner Inc.'>BWA</a> <font color='red'>-2.4%</font>), Adient (<a href='https://seekingalpha.com/symbol/ADNT' title='Adient plc'>ADNT</a> <font color='red'>-2.2%</font>), Aptiv (<a href='https://seekingalpha.com/symbol/APTV' title='Aptiv PLC'>APTV</a> <font color='red'>-1.6%</font>)</li><li>Automakers: General Motors (<a href='https://seekingalpha.com/symbol/GM' title='General Motors Company'>GM</a> <font color='red'>-0.9%</font>), Ford (<a href='https://seekingalpha.com/symbol/F' title='Ford Motor Company'>F</a> <font color='red'>-2.1%</font>), Fiat Chrysler (<a href='https://seekingalpha.com/symbol/FCAU' title='Fiat Chrysler Automobiles NV'>FCAU</a> <font color='red'>-1.8%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3366922\" data-linked=\"Trade tensions whack auto names\" data-tweet=\"$LEA $LEA $VC - Trade tensions whack auto names https://seekingalpha.com/news/3366922-trade-tensions-whack-auto-names?source=tweet\" data-url=\"https://seekingalpha.com/news/3366922-trade-tensions-whack-auto-names\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366912\" data-ts=\"1530201834\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GMS\" target=\"_blank\">GMS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366912-gms-down-20-on-q4-earnings-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GMS down 20% on Q4 earnings miss</a></h4><ul><li>GMS (<a href='https://seekingalpha.com/symbol/GMS' title='Gypsum Management and Supply'>GMS</a> <font color='red'>-20.2%</font>) reported Q4 net sales increase of 3.4% Y/Y to $635.8M, mainly driven by pricing improvement.</li><li>Net income decreased by 30.5% Y/Y to $9.9M and Adj. net income decreased by 9.3% Y/Y to $23.5M</li><li>Sales by product groups: Wallboards $279.98M (-0.77% Y/Y) with unit volumes of 878M sq ft (-3.1% Y/Y) and price improvement of 2.4%; Ceilings $95.64M (+9.32% Y/Y), steel framing $107.03M (+6.8% Y/Y) and other products $153.13M (+5.53% Y/Y).</li><li>Q4 Margins: Gross&nbsp;<font color='red'>declined by 32 bps</font>&nbsp;to 32.4% due to product mix; operating&nbsp;<font color='red'>declined&nbsp;</font><font color='red'>by 50 bps&nbsp;</font>to 4.43% and Adj. EBITDA margin<font color='red'> declined by 60 bps&nbsp;</font>to 7.9%.</li><li>SG&amp;A expenses were $161.65M (+5.7% Y/Y).</li><li>Titan update: GMS expects to record additional transaction related charges of $11-11.5M in 1Q19, including an additional $5.7M of mark-to-market currency adjustments.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3366754-gms-misses-0_09-misses-revenue\" target=\"_blank\">GMS misses by $0.09, misses on revenue</a> (June 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3366912\" data-linked=\"GMS down 20% on Q4 earnings miss\" data-tweet=\"$GMS - GMS down 20% on Q4 earnings miss https://seekingalpha.com/news/3366912-gms-down-20-on-q4-earnings-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3366912-gms-down-20-on-q4-earnings-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366920\" data-ts=\"1530201785\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBGL\" target=\"_blank\">SBGL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366920-sibanye-s-takeover-of-lonmin-approved-u-k-regulator\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sibanye\u2019s takeover of Lonmin approved by U.K. regulator</a></h4><ul>     <li>Sibanye-Stillwater (<a href='https://seekingalpha.com/symbol/SBGL' title='Sibanye-Stillwater'>SBGL</a> <font color='green'>+5.1%</font>) is higher after the U.K.&rsquo;s Competition and Markets Authority <a href=\"http://www.miningweekly.com/article/uk-regulatory-body-approves-sibanyes-acquisition-of-lonmin-2018-06-28\" target=\"_blank\">clears its proposed acquisition</a> of platinum producer Lonmin (<a href='https://seekingalpha.com/symbol/LNMIF' title='Lonmin plc'>OTC:LNMIF</a>).</li>     <li>South African competition authorities still must give their approval, which also is still subject to shareholder approval as well as approval by courts in England and Wales.</li>     <li>Separately, a U.S. law firm <a href=\"https://www.reuters.com/article/sibanye-lawsuit/class-action-lawsuit-filed-against-south-africas-sibanye-stillwater-following-fatalities-idUSL8N1TU3DH\" target=\"_blank\">files a class action lawsuit</a> against SBGL on behalf of shareholders to recover losses suffered after a spate of fatalities at its mines - 21 YTD, almost half of the total in South Africa&rsquo;s mining industry.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366920\" data-linked=\"Sibanye\u2019s takeover of Lonmin approved by U.K. regulator\" data-tweet=\"$SBGL $SBGL $LNMIF - Sibanye\u2019s takeover of Lonmin approved by U.K. regulator https://seekingalpha.com/news/3366920-sibanye-s-takeover-of-lonmin-approved-u-k-regulator?source=tweet\" data-url=\"https://seekingalpha.com/news/3366920-sibanye-s-takeover-of-lonmin-approved-u-k-regulator\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366917\" data-ts=\"1530201659\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YGYI\" target=\"_blank\">YGYI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366917-consumer-top-5-gainers-losers-of-12-00-pm-06-28-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top 5 Gainers / Losers as of 12:00 PM (06/28/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/YGYI' title='Youngevity International, Inc.'>YGYI</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/SPAR' title='Spartan Motors, Inc.'>SPAR</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/LBIX-OLD' title='Leading Brands Inc'>LBIX-OLD</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/MKC' title='McCormick & Company, Inc.'>MKC</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/FIZZ' title='National Beverage Corp.'>FIZZ</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/DFBG-OLD' title='Differential Brands Group Inc.'>DFBG-OLD</a> <font color='red'>-28%</font>. <a href='https://seekingalpha.com/symbol/XELB' title='Xcel Brands, Inc.'>XELB</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/WKHS' title='Workhorse Group Inc.'>WKHS</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/TIS' title='Orchids Paper Products Company'>TIS</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/CALM' title='Cal-Maine Foods, Inc.'>CALM</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366917\" data-linked=\"Consumer - Top 5 Gainers / Losers as of 12:00 PM (06/28/2018)\" data-tweet=\"$YGYI $YGYI $SPAR - Consumer - Top 5 Gainers / Losers as of 12:00 PM (06/28/2018) https://seekingalpha.com/news/3366917-consumer-top-5-gainers-losers-of-12-00-pm-06-28-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3366917-consumer-top-5-gainers-losers-of-12-00-pm-06-28-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366915\" data-ts=\"1530200995\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATSG\" target=\"_blank\">ATSG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366915-air-transportplus-3_6-on-stifel-boost-to-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Air Transport +3.6% on Stifel boost to Buy</a></h4><ul>   <li>Air Transport Services Group (NASDAQ:<a href='https://seekingalpha.com/symbol/ATSG' title='Air Transport Services Group, Inc'>ATSG</a>) has <font color='green'>gained 3.6%</font> in the wake of an upgrade to Buy at Stifel Nicolaus.</li>    <li>Shares spent the past couple of weeks falling off by double digits, a move caused in part by \"in-sourcing fears\" from partner Amazon.com. But the stock is more than just an Amazon story, analyst David Ross says.</li>    <li>After a 2016 long-term contract for 20 planes, ATSG hasn't added a new plane with Amazon in the past 10 months. But the company has opportunities outside the retail giant, and pilot pay increases of 40% have had only 2-3% impact on earnings, Ross notes. (h/t Bloomberg)</li>    <li>Ross boosted his price target to $26 from $23, implying 17% upside from today's higher price.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366915\" data-linked=\"Air Transport +3.6% on Stifel boost to Buy\" data-tweet=\"$ATSG - Air Transport +3.6% on Stifel boost to Buy https://seekingalpha.com/news/3366915-air-transportplus-3_6-on-stifel-boost-to-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3366915-air-transportplus-3_6-on-stifel-boost-to-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366911\" data-ts=\"1530200607\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CFRX\" target=\"_blank\">CFRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366911-contrafectplus-8_3-janney-starts-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ContraFect +8.3% as Janney starts at Buy</a></h4><ul>   <li>ContraFect (NASDAQ:<a href='https://seekingalpha.com/symbol/CFRX' title='ContraFect Corp.'>CFRX</a>) is <font color='green'>up 8.3%</font> after an initiation at Buy by Janney Montgomery Scott.</li>    <li>The firm has a price target of $4; that implies 61% upside from current price of $2.49.</li>    <li>Shares are <font color='green'>up 127.7%</font> YTD, following sharp moves up in January, February and so far in June; they're <font color='green'>up 43.8%</font> over the past 12 months.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366911\" data-linked=\"ContraFect +8.3% as Janney starts at Buy\" data-tweet=\"$CFRX - ContraFect +8.3% as Janney starts at Buy https://seekingalpha.com/news/3366911-contrafectplus-8_3-janney-starts-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3366911-contrafectplus-8_3-janney-starts-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366906\" data-ts=\"1530199993\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EZPW\" target=\"_blank\">EZPW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366906-ezcorp-gains-4_3-after-analyst-upgrades-to-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EZCORP gains 4.3% after analyst upgrades to `buy&#39;</a></h4><ul><li>EZCORP (NASDAQ:<a href='https://seekingalpha.com/symbol/EZPW' title='EZCORP, Inc.'>EZPW</a>)&nbsp;<font color='green'>+4.3%</font>&nbsp;after<a href=\"https://www.marketbeat.com/ratings/USA/latest/\" target=\"_blank\"> Sidoti upgrades</a> the stock to buy from neutral.</li><li>Some 193,148 shares changed hands by late morning, compared with its three-month daily average of 629,742.</li><li>EZCORP is down about 19% from its 52-week high of $15.10 reached on May 7.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3363345-ezcorp-acquires-23-pawn-stores-mexico\" target=\"_blank\">EZCORP acquires 23 pawn stores in Mexico</a> (June 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3366906\" data-linked=\"EZCORP gains 4.3% after analyst upgrades to `buy&#39;\" data-tweet=\"$EZPW - EZCORP gains 4.3% after analyst upgrades to `buy&#39; https://seekingalpha.com/news/3366906-ezcorp-gains-4_3-after-analyst-upgrades-to-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3366906-ezcorp-gains-4_3-after-analyst-upgrades-to-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366900\" data-ts=\"1530198953\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RPM\" target=\"_blank\">RPM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366900-rpmplus-8-after-entering-pact-elliott-seen-boosting-margins\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RPM +8% after entering pact with Elliott seen boosting margins</a></h4><ul>     <li>RPM&nbsp;International (<a href='https://seekingalpha.com/symbol/RPM' title='RPM International Inc.'>RPM</a> <font color='green'>+8.5%</font>) surges to a 52-week high after announcing an <a href=\"https://seekingalpha.com/pr/17204300-rpm-announces-agreement-elliott-management-new-initiatives-improve-operating-financial\" target=\"_blank\">agreement with activist investor Elliott Management </a>to add two board members and form a board committee to conduct a \"comprehensive business review focused on operational and financial value creating initiatives.\"</li>     <li>The two new independent directors - NRG&nbsp;Energy CFO Kirkland Andrews and longtime chemicals and coatings industry executive John Ballbach - will expand RPM's board to 14 members.</li>     <li>\"RPM has an outstanding collection of leading brands, and we believe the company has significant       potential for further operating, financial, and balance sheet improvements,\"&nbsp;Elliott says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366900\" data-linked=\"RPM +8% after entering pact with Elliott seen boosting margins\" data-tweet=\"$RPM - RPM +8% after entering pact with Elliott seen boosting margins https://seekingalpha.com/news/3366900-rpmplus-8-after-entering-pact-elliott-seen-boosting-margins?source=tweet\" data-url=\"https://seekingalpha.com/news/3366900-rpmplus-8-after-entering-pact-elliott-seen-boosting-margins\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366889\" data-ts=\"1530198395\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LNN\" target=\"_blank\">LNN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366889-on-lindsays-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Lindsay&#39;s Q3 results</a></h4><ul><li>Lindsay (<a href='https://seekingalpha.com/symbol/LNN' title='Lindsay Corporation'>LNN</a> <font color='green'>+1.5%</font>) reported Q3 revenue increase of 12% Y/Y to $169.57M due to growth in Irrigation and strong Infrastructure delivery performance.</li><li>Segment revenue: Irrigation $128.4M (+7% Y/Y), with North America irrigation revenues +11% Y/Y to $87.4M and International revenue of $41M; Infrastructure $41.2M (+31% Y/Y) driven by delivery of significant portion of two large&nbsp;orders.</li><li>Q3 gross margin slightly&nbsp;<font color='green'>improved by 6 bps</font>&nbsp;to 30.36% and operating margin&nbsp;<font color='red'>declined by 46 bps</font>&nbsp;to 11%.</li><li>Q3 segment operating margins: Irrigation&nbsp;<font color='red'>declined by 463 bps</font>&nbsp;to 9.12% and infrastructure&nbsp;<font color='green'>improved by 917 bps</font>&nbsp;to 34.6%.</li><li>Cash and cash equivalents were $111.78M as of May 31, 2018.</li><li>Backlog of unshipped orders was $558.8M as of May 31, 2018, compared to $70.1M year ago.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3366768-lindsay-beats-0_25-beats-revenue\" target=\"_blank\">Lindsay beats by $0.25, beats on revenue</a> (June 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3366889\" data-linked=\"More on Lindsay&#39;s Q3 results\" data-tweet=\"$LNN - More on Lindsay&#39;s Q3 results https://seekingalpha.com/news/3366889-on-lindsays-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3366889-on-lindsays-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366895\" data-ts=\"1530198082\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IBM\" target=\"_blank\">IBM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366895-ibmplus-1_1-on-infrastructure-agreement-kmd\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IBM +1.1% on infrastructure agreement with KMD</a></h4><ul><li>        IBM (NYSE:<a href='https://seekingalpha.com/symbol/IBM' title='International Business Machines Corporation'>IBM</a>) enters a new infrastructure outsourcing agreement with Denmark&rsquo;s KMD. The total contract value is worth over $320M.</li><li>               The deal includes moving the client to the cloud plus machine learning and other analytics.&nbsp;</li><li>               IBM will provide KMD with IT infrastructure through 2024. &nbsp;&nbsp;</li><li>               Over the next two years, KMD will invest $80M into IT infrastructure. &nbsp;&nbsp;</li><li>               IBM shares are&nbsp;<font color='green'>up 1.1%</font>&nbsp;to $138.97.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3366895\" data-linked=\"IBM +1.1% on infrastructure agreement with KMD\" data-tweet=\"$IBM - IBM +1.1% on infrastructure agreement with KMD https://seekingalpha.com/news/3366895-ibmplus-1_1-on-infrastructure-agreement-kmd?source=tweet\" data-url=\"https://seekingalpha.com/news/3366895-ibmplus-1_1-on-infrastructure-agreement-kmd\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366893\" data-ts=\"1530198063\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CFRX\" target=\"_blank\">CFRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366893-healthcare-top-5-gainers-losers-of-11-00-06-28-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 AM (06/28/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CFRX' title='ContraFect Corp.'>CFRX</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/AMRN' title='Amarin Corporation PLC'>AMRN</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/HAIR' title='Restoration Robotics'>HAIR</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/EDGE' title='Edge Therapeutics'>EDGE</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/CKPT' title='CHECKPOINT THERAPEUTICS'>CKPT</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ASNS' title='Arsanis, Inc.'>ASNS</a> <font color='red'>-66%</font>. <a href='https://seekingalpha.com/symbol/AKBA' title='Akebia Therapeutics, Inc.'>AKBA</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/RMTI' title='Rockwell Medical, Inc.'>RMTI</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/MDGS' title='Medigus Ltd'>MDGS</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/CWBR' title='CohBar Inc.'>CWBR</a> <font color='red'>-13%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366893\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 AM (06/28/2018)\" data-tweet=\"$CFRX $CFRX $AMRN - Healthcare - Top 5 Gainers / Losers as of 11:00 AM (06/28/2018) https://seekingalpha.com/news/3366893-healthcare-top-5-gainers-losers-of-11-00-06-28-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3366893-healthcare-top-5-gainers-losers-of-11-00-06-28-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366894\" data-ts=\"1530197957\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPRE\" target=\"_blank\">GPRE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366894-green-plainsminus-6-stephens-downgrades-says-chinese-ethanol-priced-in\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Green Plains -6% as Stephens downgrades, says Chinese ethanol priced in</a></h4><ul>     <li>Green Plains (<a href='https://seekingalpha.com/symbol/GPRE' title='Green Plains Inc.'>GPRE</a> <font color='red'>-6.5%</font>) plunges as much as 9.8% on heavy volume after Stephens <a href=\"https://thefly.com/thestreet/realmoney/index.php/GPREid2751793/GPRE-Green-Plains-downgraded-to-Equal-Weight-with--price-target-at-Stephens\" target=\"_blank\">downgrades</a> shares to Equal Weight from Overweight with a $20 price target, cut from $32, as the firm believes a boon from Chinese purchases of U.S. ethanol already is priced into the stock.</li>     <li>Stephens analyst Farha Aslam says GPRE&rsquo;s restructuring is a long-term positive but may lead the company \"to cut muscle\" as well; lower debt and share buybacks also are long-term positives.</li>     <li>Aslam sees current U.S. ethanol demand as lackluster while optimism over the Chinese outlook may keep production high.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366894\" data-linked=\"Green Plains -6% as Stephens downgrades, says Chinese ethanol priced in\" data-tweet=\"$GPRE - Green Plains -6% as Stephens downgrades, says Chinese ethanol priced in https://seekingalpha.com/news/3366894-green-plainsminus-6-stephens-downgrades-says-chinese-ethanol-priced-in?source=tweet\" data-url=\"https://seekingalpha.com/news/3366894-green-plainsminus-6-stephens-downgrades-says-chinese-ethanol-priced-in\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366887\" data-ts=\"1530197306\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BSET\" target=\"_blank\">BSET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366887-on-bassett-furnitures-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Bassett Furniture&#39;s Q2 results</a></h4><ul><li>Bassett Furniture (<a href='https://seekingalpha.com/symbol/BSET' title='Bassett Furniture Industries, Incorporated'>BSET</a> <font color='red'>-0.4%</font>)&nbsp;reports comparable-store sales declined 1.8% in <a href=\"https://seekingalpha.com/pr/17204611-bassett-announces-fiscal-second-quarter-results\" target=\"_blank\">Q2</a>.</li><li>Wholesale segment revenue up 2.4% to $63.8M.</li><li>Retail segment revenue increased 2.3% to $68.7M.</li><li>Logistical services revenue rose 1.2% to $24.9M.</li><li>The gross margin rate down 10 bps to 61%.</li><li>Operating margin rate squeezed 190 bps to 4.8%.</li><li>Store Count +4 Y/Y at 95.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3366850-bassett-furniture-eps-line-beats-revenue\" target=\"_blank\">Bassett Furniture EPS in-line, beats on revenue</a> (June 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3366887\" data-linked=\"More on Bassett Furniture&#39;s Q2 results\" data-tweet=\"$BSET - More on Bassett Furniture&#39;s Q2 results https://seekingalpha.com/news/3366887-on-bassett-furnitures-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3366887-on-bassett-furnitures-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366885\" data-ts=\"1530196795\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CREE\" target=\"_blank\">CREE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366885-lighting-stocks-dip-after-osram-lowers-fy-guidance-on-auto-concerns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lighting stocks dip after Osram lowers FY guidance on auto concerns</a></h4><ul><li>        Cree (<a href='https://seekingalpha.com/symbol/CREE' title='Cree, Inc.'>CREE</a> <font color='red'>-5%</font>) drops after peer Osram (<a href='https://seekingalpha.com/symbol/OSAGF' title='Osram Licht AG'>OTCPK:OSAGF</a>) <a href=\"https://www.osram-group.com/en/media/press-releases/pr-2018/28-06-2018\" target=\"_blank\">cuts its FY18 outlook</a> due to restrictions on trade and sales as well as risks affecting auto manufacturers</li><li>        Other lighting names that could move with the news: Acuity Brands (<a href='https://seekingalpha.com/symbol/AYI' title='Acuity Brands, Inc. &#40;Holding Company&#41;'>AYI</a> <font color='red'>-3.2%</font>), Philips (<a href='https://seekingalpha.com/symbol/PHG' title='Koninklijke Philips NV'>PHG</a> <font color='red'>-1%</font>), SemiLEDs (<a href='https://seekingalpha.com/symbol/LEDS' title='SemiLEDs Corporation'>LEDS</a> <font color='red'>-4.3%</font>), and Veeco Instruments (<a href='https://seekingalpha.com/symbol/VECO' title='Veeco Instruments Inc.'>VECO</a> <font color='red'>-0.4%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3366885\" data-linked=\"Lighting stocks dip after Osram lowers FY guidance on auto concerns\" data-tweet=\"$CREE $CREE $OSAGF - Lighting stocks dip after Osram lowers FY guidance on auto concerns https://seekingalpha.com/news/3366885-lighting-stocks-dip-after-osram-lowers-fy-guidance-on-auto-concerns?source=tweet\" data-url=\"https://seekingalpha.com/news/3366885-lighting-stocks-dip-after-osram-lowers-fy-guidance-on-auto-concerns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366881\" data-ts=\"1530196271\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366881-natural-gas-futures-trim-gains-post-inventory-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Natural gas futures trim gains post inventory data</a></h4><ul><li><a href=\"http://ir.eia.gov/ngs/ngs.html\" target=\"_blank\">EIA Natural Gas Inventory</a>: <strong>+66 Bcf</strong> vs. +73 Bcf consensus, +91 Bcf last week.</li><li>Futures&nbsp;<font color='green'>+0.70%</font>&nbsp;to $3.000.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>, <a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>, <a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>, <a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Ultra Bloomberg Natural Gas ETF'>BOIL</a>, <a href='https://seekingalpha.com/symbol/KOLD' title='ProShares UltraShort Bloomberg Natural Gas ETF'>KOLD</a>, <a href='https://seekingalpha.com/symbol/UNL' title='The United States 12 Month Natural Gas ETF, LP'>UNL</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366881\" data-linked=\"Natural gas futures trim gains post inventory data\" data-tweet=\"$UNG $DGAZ $UGAZ - Natural gas futures trim gains post inventory data https://seekingalpha.com/news/3366881-natural-gas-futures-trim-gains-post-inventory-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3366881-natural-gas-futures-trim-gains-post-inventory-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>37&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366880\" data-ts=\"1530196175\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLND\" target=\"_blank\">TLND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366880-talendplus-2_3-citi-steps-to-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Talend +2.3% as Citi steps to Buy</a></h4><ul><li>        Citi upgrades Talend (NASDAQ:<a href='https://seekingalpha.com/symbol/TLND' title='Talend SA'>TLND</a>) to Buy from Neutral.</li><li>                  Talend shares are&nbsp;<font color='green'>up 2.3%</font>&nbsp;to $57.50.&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3366880\" data-linked=\"Talend +2.3% as Citi steps to Buy\" data-tweet=\"$TLND - Talend +2.3% as Citi steps to Buy https://seekingalpha.com/news/3366880-talendplus-2_3-citi-steps-to-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3366880-talendplus-2_3-citi-steps-to-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366878\" data-ts=\"1530195771\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WWE\" target=\"_blank\">WWE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366878-wweplus-3_8-analysts-jack-up-targets-on-tv-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WWE +3.8% as analysts jack up targets on TV deal</a></h4><ul>   <li>World Wrestling Entertainment (NYSE:<a href='https://seekingalpha.com/symbol/WWE' title='World Wrestling Entertainment, Inc.'>WWE</a>) is <font color='green'>up 3.8%</font>, still riding momentum from its <a href=\"https://seekingalpha.com/news/3366396-wwe-plus-8_1-percent-new-u-s-flagship-deals-usa-fox\" target=\"_blank\">new U.S. distribution deals</a> for flagship shows and amid continuing price target boosts from analysts.</li>    <li>In the wake of the deal, Guggenheim raised its target yesterday to what then was a Street high of $82. Then KeyBanc raised its own target to $85, marking a new high.</li>    <li>MKM had said yesterday that the potential revenue gains could call for a $100 price target; now it's officially raised its target to a now-Street high $95 from $68. That implies 29% upside from current price of $73.51.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366878\" data-linked=\"WWE +3.8% as analysts jack up targets on TV deal\" data-tweet=\"$WWE - WWE +3.8% as analysts jack up targets on TV deal https://seekingalpha.com/news/3366878-wweplus-3_8-analysts-jack-up-targets-on-tv-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3366878-wweplus-3_8-analysts-jack-up-targets-on-tv-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366876\" data-ts=\"1530195673\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GILD\" target=\"_blank\">GILD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366876-raymond-james-initiates-gilead-35-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Raymond James initiates Gilead at 35% upside</a></h4><ul><li>        Raymond James <a href=\"https://www.streetinsider.com/New+Coverage/Raymond+James+Starts+Gilead+Sciences+%28GILD%29+at+Strong+Buy/14350726.html\" target=\"_blank\">initiates</a> Gilead Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a>) with a Strong Buy rating and a $93 price target, a 35% upside to yesterday&rsquo;s close.</li><li>               Gilead Sciences shares are&nbsp;<font color='green'>up 1.1%</font>&nbsp;to $69.40.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3366876\" data-linked=\"Raymond James initiates Gilead at 35% upside\" data-tweet=\"$GILD - Raymond James initiates Gilead at 35% upside https://seekingalpha.com/news/3366876-raymond-james-initiates-gilead-35-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3366876-raymond-james-initiates-gilead-35-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>36&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366862\" data-ts=\"1530194717\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APOG\" target=\"_blank\">APOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366862-apogee-enterprises-up-8-on-q1-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apogee Enterprises up 8% on Q1 earnings beat</a></h4><ul><li>Apogee Enterprises (<a href='https://seekingalpha.com/symbol/APOG' title='Apogee Enterprises, Inc.'>APOG</a> <font color='green'>+8.1%</font>) reported Q1 revenue growth of 23.6% Y/Y to $336.53M due to acquisitions, organic growth and +60% Y/Y growth in Architectural framing systems segment.</li><li>Segment revenues: Architectural framing systems $179.04M (+63% Y/Y), architectural glass $76.92M (-21% Y/Y), architectural services $70.73M (+41% Y/Y), large-scale optical $20.76M (+12% Y/Y).</li><li>Q1 Overall margins: Gross <font color='red'>declined by 183 bps</font>&nbsp;to 24%;&nbsp;operating&nbsp;<font color='red'>declined by 232 bps</font>&nbsp;to 6.5% and Adj. operating <font color='red'>declined by 247 bps</font>&nbsp;to 7.4%.</li><li>Q1 Segment operating margins: Architectural framing systems&nbsp;<font color='red'>declined by 390 bps</font>&nbsp;to 6.9% due to the inclusion of lower margin EFCO sales; Architectural glass&nbsp;<font color='red'>declined by 740 bps</font>&nbsp;to 2.1%; Architectural services&nbsp;<font color='green'>improved by 570 bps&nbsp;</font>to 7.3% and Large-Scale optical technologies&nbsp;<font color='green'>improved by 220 bps</font>&nbsp;to 24%.</li><li>SG&amp;A expenses were $57.73M up by 27.17% Y/Y.</li><li>Backlog at the end of Q1: Architectural framing systems $427M vs $ 255.1M year ago and Architectural services $439.1M vs $292.2M year ago.</li><li><strong>FY19 Outlook:</strong> Revenue growth ~10%; operating margin 8.9-9.4%; Adj. operating margin 9.2-9.7%; EPS $3.35-3.55 from $3.30-3.50 earlier; Adj. EPS $3.48-3.68 from $3.43-3.63 earlier; Capex $60-65M and Tax rate ~24%.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3366764-apogee-beats-0_09-beats-revenue\" target=\"_blank\">Apogee beats by $0.09, beats on revenue</a> (June 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3366862\" data-linked=\"Apogee Enterprises up 8% on Q1 earnings beat\" data-tweet=\"$APOG - Apogee Enterprises up 8% on Q1 earnings beat https://seekingalpha.com/news/3366862-apogee-enterprises-up-8-on-q1-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3366862-apogee-enterprises-up-8-on-q1-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366858\" data-ts=\"1530193946\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FC\" target=\"_blank\">FC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366858-franklin-covey-up-2_5-post-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Franklin Covey up 2.5% post Q3 results</a></h4><ul><li>Franklin Covey (<a href='https://seekingalpha.com/symbol/FC' title='Franklin Covey Company'>FC</a> <font color='green'>+2.5%</font>) <a href=\"https://seekingalpha.com/filing/4080990\" target=\"_blank\">reports Q3</a> revenue growth of 15.3% Y/Y to $50.5M.</li><li>Gross margin&nbsp;<font color='green'>increased 670 bps</font>&nbsp;to 69.2%, the increase was primarily due to a change in the mix of revenues, as subscription revenues, including the All Access Pass, continue to grow as a percentage of recognized sales.</li><li>Subscription Services momentum further strengthens with Paying Subscribers up 37% Y/Y to 540,000.</li><li>Deferred Subscription revenue increases 46% Y/Y to $34.5M, additional investments expected to add growth in fiscal 2019 and beyond.</li><li>Unbilled deferred revenue which represents business that is contracted but unbilled were $15.1M (+504% Y/Y).</li><li>Adjusted EBITDA improved to $0.6M for Q3.</li><li>The Company had $11.8M of cash &amp; $14.1M of available borrowing capacity on its revolving line of credit facility.</li><li><strong>2018 Outlook:</strong> The Company reaffirms its previously announced Adj. EBITDA to be $10-15M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366858\" data-linked=\"Franklin Covey up 2.5% post Q3 results\" data-tweet=\"$FC - Franklin Covey up 2.5% post Q3 results https://seekingalpha.com/news/3366858-franklin-covey-up-2_5-post-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3366858-franklin-covey-up-2_5-post-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366859\" data-ts=\"1530193714\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UPLD\" target=\"_blank\">UPLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366859-upland-acquires-customer-reference-solution-provider-sharesplus-3_2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Upland acquires customer reference solution provider; shares +3.2%</a></h4><ul><li>           Upland Software (NASDAQ:<a href='https://seekingalpha.com/symbol/UPLD' title='Upland Software'>UPLD</a>) <a href=\"https://seekingalpha.com/pr/17204746-upland-software-announces-acquisition-raises-guidance\" target=\"_blank\">acquires</a> RO Innovation, provider of cloud-based customer reference solutions. Upland paid $12.5M in cash at closing, net of cash acquired, and a $1.75M cash holdback payable in a year. </li><li> RO Innovation will be combined with Upland&rsquo;s Qvidian cloud-based RFP and sales proposal automation solution. </li><li> Upland says the deal is immediately accretive to its adjusted EBITDA per share and adds about $6M in annualized revenue. </li><li> Upland raises its FY18 guidance to revenue of $135.7M to $138.7M with subscription and support revenue of $121.8M to $124.8M. Adjusted EBITDA expected between $48.1M and $50.1M. &nbsp; </li><li> Upland Software shares are&nbsp;<font color='green'>up 3.2%</font>&nbsp;to $33.65.&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3366859\" data-linked=\"Upland acquires customer reference solution provider; shares +3.2%\" data-tweet=\"$UPLD - Upland acquires customer reference solution provider; shares +3.2% https://seekingalpha.com/news/3366859-upland-acquires-customer-reference-solution-provider-sharesplus-3_2?source=tweet\" data-url=\"https://seekingalpha.com/news/3366859-upland-acquires-customer-reference-solution-provider-sharesplus-3_2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366857\" data-ts=\"1530193395\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PIR\" target=\"_blank\">PIR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366857-pier-1s-sinking-sales-test-analyst-patience-for-turnaround-shares-openminus-24\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pier 1&#39;s sinking sales test analyst patience for turnaround; shares open -24%</a></h4><ul>     <li>Pier 1 Imports (<a href='https://seekingalpha.com/symbol/PIR' title='Pier 1 Imports Inc.'>PIR</a> <font color='red'>-24%</font>) opens more than 20% lower after <a href=\"https://seekingalpha.com/news/3366720-pier-1-plunges-15-percent-q1-store-sales-fall-expected\" target=\"_blank\">same-store sales dropped 8.2%</a> in Q1, which Morgan Stanley calls &ldquo;another step-down&rdquo;  for the company, adding that Q2 guidance also was worse than expected.</li><li>Stanley's Simeon Gutman says disappointing sales and margin numbers could suggest that  promotions are becoming less effective, and adds that 2018 PIR's comps outlook may be out of reach; the firm rates PIR at Underweight with a $2.25 price target.</li><li>But some analysts are not abandoning PIR, with Guggenheim advising investors to wait for H2 to see if a pending brand relaunch is effective.</li><li>Guggenheim's Steven Forbes, who rates the stock Neutral, sees Q1 results as &ldquo;essentially in-line,&rdquo; driven mostly by strong cost control despite poor  sales and margin numbers.</li><li>Source:&nbsp;Bloomberg First Word</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366857\" data-linked=\"Pier 1&#39;s sinking sales test analyst patience for turnaround; shares open -24%\" data-tweet=\"$PIR - Pier 1&#39;s sinking sales test analyst patience for turnaround; shares open -24% https://seekingalpha.com/news/3366857-pier-1s-sinking-sales-test-analyst-patience-for-turnaround-shares-openminus-24?source=tweet\" data-url=\"https://seekingalpha.com/news/3366857-pier-1s-sinking-sales-test-analyst-patience-for-turnaround-shares-openminus-24\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366851\" data-ts=\"1530193182\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MAT\" target=\"_blank\">MAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366851-mattelminus-3_6-d-davidson-cuts-to-neutral-on-lagging-fundamentals\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mattel -3.6% as D.A. Davidson cuts to neutral on lagging fundamentals</a></h4><ul><li>Mattel (<a href='https://seekingalpha.com/symbol/MAT' title='Mattel, Inc.'>MAT</a> <font color='red'>-3.6%</font>) falls after D.A. Davidson analyst Linda Bolton Weiser downgraded the toy and game maker to underperform from neutral, Bloomberg reports.</li><li>While shares have rebounded 29% from April 20 low, fundamentals haven't improved, Bolton writes; she cut her Q2 estimates for sales, operating profit, EPS to below consensus on disruption and light shipments stemming from the Toys \"R\" Us liquidation.</li><li>Mattel has 4 buys, 10 holds, 2 sells, average price target $17: Bloomberg data.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3364839-ubs-reels-expectations-mattel\" target=\"_blank\">UBS reels in expectations on Mattel</a> (June 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3366851\" data-linked=\"Mattel -3.6% as D.A. Davidson cuts to neutral on lagging fundamentals\" data-tweet=\"$MAT - Mattel -3.6% as D.A. Davidson cuts to neutral on lagging fundamentals https://seekingalpha.com/news/3366851-mattelminus-3_6-d-davidson-cuts-to-neutral-on-lagging-fundamentals?source=tweet\" data-url=\"https://seekingalpha.com/news/3366851-mattelminus-3_6-d-davidson-cuts-to-neutral-on-lagging-fundamentals\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366843\" data-ts=\"1530192455\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DFBG-OLD\" target=\"_blank\">DFBG-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366843-premarket-losers-of-9-05-06-28-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (06/28/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/DFBG-OLD' title='Differential Brands Group Inc.'>DFBG-OLD</a>&nbsp;<font color='red'>-17%</font>&nbsp;<a href=\"https://seekingalpha.com/news/3366492-differential-brands-acquire-majority-north-american-division-global-brands-group-1_38b-plus\" target=\"_blank\">retreating</a> after yesterday's gain.</li>     <li><a href='https://seekingalpha.com/symbol/PIR' title='Pier 1 Imports Inc.'>PIR</a>&nbsp;<font color='red'>-15%</font>&nbsp;as Q1 <a href=\"https://seekingalpha.com/news/3366720-pier-1-plunges-15-percent-q1-store-sales-fall-expected\" target=\"_blank\">same-store sales fall</a> more than expected.</li>     <li><a href='https://seekingalpha.com/symbol/TRXC' title='TransEnterix, Inc.'>TRXC</a>&nbsp;<font color='red'>-12%</font>&nbsp;as BTIG <a href=\"https://seekingalpha.com/news/3366785-btig-rings-register-transenterix\" target=\"_blank\">rings the register</a> on TransEnterix.</li>     <li><a href='https://seekingalpha.com/symbol/WBA' title='Walgreens Boots Alliance, Inc.'>WBA</a>&nbsp;<font color='red'>-9%</font>&nbsp;on Q3 <a href=\"https://seekingalpha.com/news/3366778-walgreens-boots-beats-0_05-beats-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/CVS' title='CVS Health Corporation'>CVS</a>&nbsp;<font color='red'>-9%</font>&nbsp;as Pharmacy, drug distributor <a href=\"https://seekingalpha.com/news/3366833-pharmacy-drug-distributor-stocks-fall-amazons-pillpack-acquisition\" target=\"_blank\">stocks fall</a> on Amazon's PillPack acquisition.</li>     <li><a href='https://seekingalpha.com/symbol/SNGX' title='Soligenix, Inc.'>SNGX</a>&nbsp;<font color='red'>-9%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3366757-soligenix-prices-8m-public-offering\" target=\"_blank\">pricing</a> $8M public offering.</li>     <li><a href='https://seekingalpha.com/symbol/GEVO' title='Gevo, Inc.'>GEVO</a>&nbsp;<font color='red'>-7%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/BBBY' title='Bed Bath & Beyond Inc.'>BBBY</a>&nbsp;<font color='red'>-7%</font>&nbsp;on Q1 <a href=\"https://seekingalpha.com/news/3366680-bed-bath-and-beyond-beats-0_06-revenue-line\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/SMMT' title='Summit Therapeutics'>SMMT</a>&nbsp;<font color='red'>-6%</font>&nbsp;<a href=\"https://seekingalpha.com/news/3366641-summit-therapeutics-minus-80-percent-discontinuing-top-drug-candidate\" target=\"_blank\">after</a> discontinuing top drug candidate.</li>     <li><a href='https://seekingalpha.com/symbol/RAD' title='Rite Aid Corporation'>RAD</a>&nbsp;<font color='red'>-6%</font>&nbsp;on Q1&nbsp;<a href=\"https://seekingalpha.com/news/3366677-rite-aid-eps-line-beats-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/CMG' title='Chipotle Mexican Grill, Inc.'>CMG</a>&nbsp;<font color='red'>-5%</font>&nbsp;as strategic <a href=\"https://seekingalpha.com/news/3366842-chipotle-s-strategic-update-seen-very-limited-analysts-shares-minus-5-percent\" target=\"_blank\">update</a> seen as 'very limited' by analysts.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366843\" data-linked=\"Premarket Losers as of 9:05 am (06/28/2018)\" data-tweet=\"$DFBG-OLD $DFBG-OLD $PIR - Premarket Losers as of 9:05 am (06/28/2018) https://seekingalpha.com/news/3366843-premarket-losers-of-9-05-06-28-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3366843-premarket-losers-of-9-05-06-28-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366842\" data-ts=\"1530192363\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMG\" target=\"_blank\">CMG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366842-chipotle-s-strategic-update-seen-very-limited-analysts-sharesminus-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chipotle\u2019s strategic update seen as &#39;very limited&#39; by analysts; shares -5%</a></h4><ul>     <li>Chipotle Mexican Grill (NYSE:<a href='https://seekingalpha.com/symbol/CMG' title='Chipotle Mexican Grill, Inc.'>CMG</a>) <font color='red'>-5.4%</font> premarket after <a href=\"https://seekingalpha.com/news/3366725-chipotle-take-115m-135m-charge-store-closings-restructure\" target=\"_blank\">yesterday's strategic update</a> left investors underwhelmed.</li>     <li>CEO Brian Niccol&rsquo;s initiatives to drive up sales, including a focus on digitizing and modernizing restaurants, are viewed by analysts as the right moves but details on a timeline for expected results were called \"very  limited\" by Karen Holthouse at Goldman Sachs.</li><li>CMG also failed to comment on the current quarter other than to  say sales trends from Q1 have continued, and Holthouse thinks this may imply a potential shortfall vs. a consensus estimate of 2.5% comparable sales growth; Goldman rates the stock Neutral with a $450 price target.</li><li>While CMG&rsquo;s call to outline its strategic priorities hit on all the  expected high level topics, Morgan Stanley's John Glass says it lacked detail needed to provide a clearer  path to ~$20 or more in EPS by 2020, which Glass thinks is needed to drive the stock higher; the firm rates CMG at Equal Weight with a $372 target.</li><li>With shares near a 52-week high, Wells Fargo's Jon Tower thinks investors were expecting more  clarity on timing and financial impact of CMG's initiatives and without those details,  shares likely will come under pressure; Wells rates CMG at Market Perform with a $405 price target.</li><li>Source:&nbsp;Bloomberg First Word</li></ul><div class=\"tiny-share-widget\" data-id=\"3366842\" data-linked=\"Chipotle\u2019s strategic update seen as &#39;very limited&#39; by analysts; shares -5%\" data-tweet=\"$CMG - Chipotle\u2019s strategic update seen as &#39;very limited&#39; by analysts; shares -5% https://seekingalpha.com/news/3366842-chipotle-s-strategic-update-seen-very-limited-analysts-sharesminus-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3366842-chipotle-s-strategic-update-seen-very-limited-analysts-sharesminus-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366840\" data-ts=\"1530192205\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MOMO\" target=\"_blank\">MOMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366840-momoplus-1_6-responds-to-spruce-point-short-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Momo +1.6% as it responds to Spruce Point short report</a></h4><ul>   <li>Momo (NASDAQ:<a href='https://seekingalpha.com/symbol/MOMO' title='Momo'>MOMO</a>) is <font color='green'>up 1.6%</font> premarket after <a href=\"https://seekingalpha.com/pr/17204576-momo-inc-responds-short-seller-report\" target=\"_blank\">responding this morning</a> to a short report from Spruce Point Capital Management.</li>    <li>Shares <font color='red'>fell 5.5%</font> yesterday after Spruce Point <a href=\"https://seekingalpha.com/news/3366640-momo-minus-6_9-percent-spruce-point-report-alleging-serious-risks\" target=\"_blank\">pointed to 30-50% downside risk</a> based on \"serious risks\" exposed through what it said was forensic research from a China-based investigator.</li>    <li>Momo says it believes Spruce Point's report \"contains numerous errors, unsubstantiated statements and misleading conclusions and interpretations regarding events relating to the company.\"</li>    <li>Momo says it's still committed to maintaining high standards in governance and transparent and timely disclosures.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366840\" data-linked=\"Momo +1.6% as it responds to Spruce Point short report\" data-tweet=\"$MOMO - Momo +1.6% as it responds to Spruce Point short report https://seekingalpha.com/news/3366840-momoplus-1_6-responds-to-spruce-point-short-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3366840-momoplus-1_6-responds-to-spruce-point-short-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366838\" data-ts=\"1530191887\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBR\" target=\"_blank\">GBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366838-premarket-gainers-of-9-05-6-28-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (6/28/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/GBR' title='New Concept Energy, Inc.'>GBR</a> <font color='green'>+150%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/PED' title='PEDEVCO Corp.'>PED</a> <font color='green'>+43%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a> <font color='green'>+29%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3366824-saexploration-plus-33-percent-deal-buy-geokinetics-assets-bankruptcy\" target=\"_blank\">deal</a> to buy Geokinetics assets out of bankruptcy.</li>     <li><a href='https://seekingalpha.com/symbol/CLDC' title='China Lending Corporation'>CLDC</a> <font color='green'>+17%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/ZSAN' title='Zosano Pharma'>ZSAN</a> <font color='green'>+11%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17203727-zosano-present-additional-analyses-zotrip-pivotal-study-pain-relief-recurrence-2018-american\" target=\"_blank\">additional</a> analyses from the ZOTRIP pivotal study on pain relief and recurrence.</li>     <li><a href='https://seekingalpha.com/symbol/RCON' title='Recon Technology, Ltd.'>RCON</a> <font color='green'>+10%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/OTIV' title='On Track Innovations Ltd'>OTIV</a> <font color='green'>+10%</font>&nbsp;on&nbsp;<a href=\"https://seekingalpha.com/news/3366822-track-innovations-receives-purchase-order-3000-cashless-payment-systems-japanese-market\" target=\"_blank\">purchase</a> order for 3,000 cashless payment systems for the Japanese market.</li>     <li>CAVM <font color='green'>+10%</font>&nbsp;on Chinese <a href=\"https://seekingalpha.com/news/3366798-marvell-plus-11_8-percent-chinese-approval-cavium-deal\" target=\"_blank\">approval</a> for Cavium deal.</li>     <li><a href='https://seekingalpha.com/symbol/RPM' title='RPM International Inc.'>RPM</a> <font color='green'>+9%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17204300-rpm-announces-agreement-elliott-management-new-initiatives-improve-operating-financial\" target=\"_blank\">agreement</a> with Elliott Management.</li>     <li><a href='https://seekingalpha.com/symbol/EDGE' title='Edge Therapeutics'>EDGE</a> <font color='green'>+9%</font>&nbsp;as it <a href=\"https://seekingalpha.com/news/3366708-edge-therapeutics-plus-45_6-percent-discloses-study-data-strategic-update\" target=\"_blank\">discloses</a> study data, strategic update.</li>     <li><a href='https://seekingalpha.com/symbol/LTBR' title='Lightbridge Corp'>LTBR</a> <font color='green'>+8%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17204244-lightbridge-receives-patent-approval-advanced-metallic-fuel-rod-fuel-assembly-design-japan\" target=\"_blank\">new</a> patent in&nbsp;Japan&nbsp;related to Lightbridge's innovative metallic fuel rod and fuel assembly design.</li>     <li><a href='https://seekingalpha.com/symbol/AKBA' title='Akebia Therapeutics, Inc.'>AKBA</a> <font color='green'>+8%&nbsp;</font>on Keryx Biopharma agree to <a href=\"https://seekingalpha.com/news/3366786-akebia-therapeutics-keryx-biopharma-agree-merge\" target=\"_blank\">merge</a>.</li>     <li><a href='https://seekingalpha.com/symbol/WATT' title='Energous Corp.'>WATT</a> <font color='green'>+8%</font>&nbsp;on IDT <a href=\"https://seekingalpha.com/news/3366803-energous-plus-4_7-percent-idt-partnership\" target=\"_blank\">partnership</a>.</li>     <li><a href='https://seekingalpha.com/symbol/MRVL' title='Marvell Technology Group, Ltd.'>MRVL</a> <font color='green'>+8%</font>&nbsp;on Chinese&nbsp;<a href=\"https://seekingalpha.com/news/3366798-marvell-plus-11_8-percent-chinese-approval-cavium-deal\" target=\"_blank\">approval</a>&nbsp;for Cavium deal.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366838\" data-linked=\"Premarket Gainers as of 9:05 am (6/28/2018)\" data-tweet=\"$GBR $GBR $PED - Premarket Gainers as of 9:05 am (6/28/2018) https://seekingalpha.com/news/3366838-premarket-gainers-of-9-05-6-28-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3366838-premarket-gainers-of-9-05-6-28-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366836\" data-ts=\"1530191812\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MSG\" target=\"_blank\">MSG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366836-msgplus-10-jefferies-boosts-to-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MSG +10% as Jefferies boosts to Buy</a></h4><ul>   <li>Madison Square Garden (NASDAQ:<a href='https://seekingalpha.com/symbol/MSG' title='The Madison Square Garden Company'>MSG</a>) is <font color='green'>up 10.4%</font> premarket the morning after it announced it would <a href=\"https://seekingalpha.com/news/3366690-madison-square-garden-plus-1_8-percent-eyes-spin-sports-businesses\" target=\"_blank\">consider spinning off its sports operations</a> into a separate business from live entertainment, and Jefferies lifts its view in response.</li>    <li>Analyst John Janedis has upgraded to Buy from Hold.</li>    <li>He's raised price target to $350 from $233, implying 31% upside.</li>    <li>Shares are <font color='green'>up 26.3%</font> YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366836\" data-linked=\"MSG +10% as Jefferies boosts to Buy\" data-tweet=\"$MSG - MSG +10% as Jefferies boosts to Buy https://seekingalpha.com/news/3366836-msgplus-10-jefferies-boosts-to-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3366836-msgplus-10-jefferies-boosts-to-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366833\" data-ts=\"1530191331\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WBA\" target=\"_blank\">WBA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366833-pharmacy-drug-distributor-stocks-fall-on-amazons-pillpack-acquisition\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pharmacy, drug distributor stocks fall on Amazon&#39;s PillPack acquisition</a></h4><ul><li>Retail pharmacy and drug distributor stocks are on the move after Amazon&rsquo;s announced acquisition of online pharmacy startup PillPack.</li><li>On the move premarket: Walgreens Boots (NASDAQ:<a href='https://seekingalpha.com/symbol/WBA' title='Walgreens Boots Alliance, Inc.'>WBA</a>)&nbsp;<font color='red'>down 8.8%</font>, CVS (NYSE:<a href='https://seekingalpha.com/symbol/CVS' title='CVS Health Corporation'>CVS</a>)&nbsp;<font color='red'>down 8.6%</font>, Rite Aid (NYSE:<a href='https://seekingalpha.com/symbol/RAD' title='Rite Aid Corporation'>RAD</a>)&nbsp;<font color='red'>down 6.6%</font>, Diplomat Pharmacy (NYSE:<a href='https://seekingalpha.com/symbol/DPLO' title='Diplomat Pharmacy'>DPLO</a>)&nbsp;<font color='red'>down 4.1%</font>, Express Scripts (NASDAQ:<a href='https://seekingalpha.com/symbol/ESRX' title='Express Scripts, Inc.'>ESRX</a>)&nbsp;<font color='red'>down 3.3%</font>, McKesson (NYSE:<a href='https://seekingalpha.com/symbol/MCK' title='McKesson Corporation'>MCK</a>)&nbsp;<font color='red'>down 3.2%</font>, Cardinal Health (NYSE:<a href='https://seekingalpha.com/symbol/CAH' title='Cardinal Health Inc.'>CAH</a>)&nbsp;<font color='red'>down 5.1%</font>, AmerisourceBergen (NYSE:<a href='https://seekingalpha.com/symbol/ABC' title='AmerisourceBergen Corporation'>ABC</a>)&nbsp;<font color='red'>down 4.3%</font>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3366821-amazon-acquires-online-pharmacy-start-pillpack\" target=\"_blank\">Amazon acquires online pharmacy start-up PillPack</a> (June 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3366833\" data-linked=\"Pharmacy, drug distributor stocks fall on Amazon&#39;s PillPack acquisition\" data-tweet=\"$WBA $WBA $CVS - Pharmacy, drug distributor stocks fall on Amazon&#39;s PillPack acquisition https://seekingalpha.com/news/3366833-pharmacy-drug-distributor-stocks-fall-on-amazons-pillpack-acquisition?source=tweet\" data-url=\"https://seekingalpha.com/news/3366833-pharmacy-drug-distributor-stocks-fall-on-amazons-pillpack-acquisition\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>113&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366827\" data-ts=\"1530190815\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LSCC\" target=\"_blank\">LSCC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366827-lattice-semiplus-2_9-on-dougherty-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lattice Semi +2.9% on Dougherty upgrade</a></h4><ul><li>        Dougherty<a href=\"https://www.streetinsider.com/New+Coverage/Dougherty+%26+Co+Starts+Lattice+Semiconductor+%28LSCC%29+at+Buy/14352173.html\" target=\"_blank\"> upgrades</a> Lattice Semiconductor (NASDAQ:<a href='https://seekingalpha.com/symbol/LSCC' title='Lattice Semiconductor Corporation'>LSCC</a>) with a Buy rating and a $10 price target, a 62% upside to yesterday&rsquo;s close.&nbsp;</li><li>               Lattice Semiconductor shares are&nbsp;<font color='green'>up 2.9%</font>&nbsp;to $6.36.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3366827\" data-linked=\"Lattice Semi +2.9% on Dougherty upgrade\" data-tweet=\"$LSCC - Lattice Semi +2.9% on Dougherty upgrade https://seekingalpha.com/news/3366827-lattice-semiplus-2_9-on-dougherty-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3366827-lattice-semiplus-2_9-on-dougherty-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366826\" data-ts=\"1530190317\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HIMX\" target=\"_blank\">HIMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366826-himaxminus-1_5-on-cowen-initiation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Himax -1.5% on Cowen initiation</a></h4><ul><li>Cowen <a href=\"https://www.streetinsider.com/New+Coverage/Cowen+Starts+Himax+Technologies+%28HIMX%29+at+Market+Perform/14351591.html\" target=\"_blank\">initiates</a> Himax Tech (NASDAQ:<a href='https://seekingalpha.com/symbol/HIMX' title='Himax Technologies, Inc.'>HIMX</a>) with a Market Perform rating.</li><li>Himax shares are&nbsp;<font color='red'>down 1.5%</font>&nbsp;premarket to $7.46.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366826\" data-linked=\"Himax -1.5% on Cowen initiation\" data-tweet=\"$HIMX - Himax -1.5% on Cowen initiation https://seekingalpha.com/news/3366826-himaxminus-1_5-on-cowen-initiation?source=tweet\" data-url=\"https://seekingalpha.com/news/3366826-himaxminus-1_5-on-cowen-initiation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366824\" data-ts=\"1530190281\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAEX\" target=\"_blank\">SAEX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366824-saexplorationplus-33-on-deal-to-buy-geokinetics-assets-out-of-bankruptcy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SAExploration +33% on deal to buy Geokinetics assets out of bankruptcy</a></h4><ul>     <li>SAExploration (NASDAQ:<a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a>)&nbsp;<font color='green'>+33.1%</font> premarket after saying it has entered into an asset purchase deal that will be used as a <a href=\"https://seekingalpha.com/pr/17204021-saexploration-acquire-assets-geokinetics-bankruptcy\" target=\"_blank\">stalking horse bid to acquire certain assets</a> of Geokinetics, which is in Chapter 11 bankruptcy.</li>     <li>The assets SAEX has offered to acquire include equipment and machinery, seismic processing software and equipment, and certain contracts with large exploration and production companies.</li>     <li>SAEX expects the deal to allow it to \"create relationships with new customers in new markets\" and to capture meaningful cost synergies by reducing or eliminating the need to rent equipment.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366824\" data-linked=\"SAExploration +33% on deal to buy Geokinetics assets out of bankruptcy\" data-tweet=\"$SAEX - SAExploration +33% on deal to buy Geokinetics assets out of bankruptcy https://seekingalpha.com/news/3366824-saexplorationplus-33-on-deal-to-buy-geokinetics-assets-out-of-bankruptcy?source=tweet\" data-url=\"https://seekingalpha.com/news/3366824-saexplorationplus-33-on-deal-to-buy-geokinetics-assets-out-of-bankruptcy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366821\" data-ts=\"1530189852\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366821-amazon-acquires-online-pharmacy-start-up-pillpack\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amazon acquires online pharmacy start-up PillPack</a></h4><ul><li>Amazon (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>) <a href=\"https://seekingalpha.com/pr/17204492-amazon-acquire-pillpack\" target=\"_blank\">acquires</a> online pharmacy start-up PillPack for undisclosed terms.</li><li>PillPack delivers medications in pre-sorted dose packaging plus handles refills and renewals.</li><li>The parties expect the transaction to close during 2H18.</li><li>Earlier this year, Walmart (NYSE:<a href='https://seekingalpha.com/symbol/WMT' title='Walmart Inc.'>WMT</a>) neared a PillPack acquisition with <a href=\"https://www.cnbc.com/2018/04/02/walmart-buying-pillpack-online-pharmacy-sources.html\" target=\"_blank\">CNBC sources</a> saying the retailer would pay less than $1B.</li><li>PillPack has raised over $118M in funding from backers including Menlo Ventures. The startup said it reached over $100M in revenue last year. The valuation stood at $330M as of 2016.</li><li>Amazon shares are&nbsp;<font color='red'>down 0.1%</font>&nbsp;premarket.</li><li>Walmart shares are&nbsp;<font color='red'>down 1.2%.&nbsp;</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3366821\" data-linked=\"Amazon acquires online pharmacy start-up PillPack\" data-tweet=\"$AMZN $AMZN $WMT - Amazon acquires online pharmacy start-up PillPack https://seekingalpha.com/news/3366821-amazon-acquires-online-pharmacy-start-up-pillpack?source=tweet\" data-url=\"https://seekingalpha.com/news/3366821-amazon-acquires-online-pharmacy-start-up-pillpack\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>105&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366813\" data-ts=\"1530189012\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRM\" target=\"_blank\">CRM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366813-salesforceplus-1_2-bmo-names-top-pick-raises-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Salesforce +1.2% as BMO names it a top pick, raises target</a></h4><ul><li>        BMO Capital names Salesforce (NYSE:<a href='https://seekingalpha.com/symbol/CRM' title='Salesforce.com, Inc.'>CRM</a>) a top pick, replacing Adobe (NASDAQ:<a href='https://seekingalpha.com/symbol/ADBE' title='Adobe Systems Incorporated'>ADBE</a>), and raises the price target from $147 to $152.</li><li>               Analyst Keith Bachman says the firm is &ldquo;bullish on companies that can leverage large data pools on behalf of their customers.&rdquo;&nbsp;</li><li>               The analyst says the decision to move Salesforce ahead of Adobe is primarily based on the latter&rsquo;s multiple and the fact that Salesforce has more room to expand its operating margins.&nbsp;</li><li>               Source: Bloomberg First Word.&nbsp;</li><li>               Salesforce shares are&nbsp;<font color='green'>up 1.2%</font>&nbsp;premarket to $134.80.&nbsp;</li><li>               Adobe shares are&nbsp;<font color='green'>up 0.1%</font>&nbsp;premarket to $237.91.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3366813\" data-linked=\"Salesforce +1.2% as BMO names it a top pick, raises target\" data-tweet=\"$CRM $CRM $ADBE - Salesforce +1.2% as BMO names it a top pick, raises target https://seekingalpha.com/news/3366813-salesforceplus-1_2-bmo-names-top-pick-raises-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3366813-salesforceplus-1_2-bmo-names-top-pick-raises-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366805\" data-ts=\"1530187763\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366805-tesla-bulls-bullish-on-production\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesla bulls bullish on production</a></h4><ul><li>Baird's Ben Kallo reiterates his Outperform rating and adds Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) to his \"Fresh Pick\" list until July 7, telling clients to buy ahead of the Q2 delivery release.</li><li>If Model 3 production gets near 5K per week, says Kallo, the stock's a buy. There's also a chance Tesla could outline a path to production topping 5K per week.</li><li>Following a tour of the Nevada Gigafactory, Berenberg's&nbsp;Alexander Haissl says key module bottlenecks have been overcome and production has ramped. The company's&nbsp;thermal management technology is under-appreciated and a key competitive advantage, says Haissl.</li><li>Source: Bloomberg's Gregory Calderone.</li><li>Shares&nbsp;<font color='green'>+1.3%</font>&nbsp;premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3366805\" data-linked=\"Tesla bulls bullish on production\" data-tweet=\"$TSLA - Tesla bulls bullish on production https://seekingalpha.com/news/3366805-tesla-bulls-bullish-on-production?source=tweet\" data-url=\"https://seekingalpha.com/news/3366805-tesla-bulls-bullish-on-production\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>203&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366803\" data-ts=\"1530187504\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WATT\" target=\"_blank\">WATT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366803-energousplus-4_7-on-idt-partnership\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energous +4.7% on IDT partnership</a></h4><ul><li>        Energous (NASDAQ:<a href='https://seekingalpha.com/symbol/WATT' title='Energous Corp.'>WATT</a>) and IDT <a href=\"https://seekingalpha.com/pr/17204190-energous-partners-idt-launch-wattup-near-field-wireless-charging-2_0\" target=\"_blank\">partner</a> for a cost-effective near field warless charging transmitter.</li><li>               The partnership allows customers to bundle a standard IDT transmitter design with WattUp receiver technology.&nbsp;</li><li>               Energous shares are&nbsp;<font color='green'>up 4.7%</font>&nbsp;premarket to $15.90.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3366803\" data-linked=\"Energous +4.7% on IDT partnership\" data-tweet=\"$WATT - Energous +4.7% on IDT partnership https://seekingalpha.com/news/3366803-energousplus-4_7-on-idt-partnership?source=tweet\" data-url=\"https://seekingalpha.com/news/3366803-energousplus-4_7-on-idt-partnership\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366802\" data-ts=\"1530187473\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SJR\" target=\"_blank\">SJR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366802-shaw-communications-reports-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shaw Communications reports Q3 results</a></h4><ul><li>Shaw Communications (NYSE:<a href='https://seekingalpha.com/symbol/SJR' title='Shaw Communications Inc.'>SJR</a>): Q3 EPS of -C$0.18</li><li>Revenue of C$1.3B (+6.6% Y/Y)</li><li>Shares <font color='green'>+2.79%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17204373-shaw-announces-third-quarter-year-date-fiscal-2018-results\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3366802\" data-linked=\"Shaw Communications reports Q3 results\" data-tweet=\"$SJR - Shaw Communications reports Q3 results https://seekingalpha.com/news/3366802-shaw-communications-reports-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3366802-shaw-communications-reports-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:04 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366798\" data-ts=\"1530186980\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRVL\" target=\"_blank\">MRVL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366798-marvellplus-11_8-on-chinese-approval-for-cavium-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marvell +11.8% on Chinese approval for Cavium deal</a></h4><ul><li>        Marvell&rsquo;s (NASDAQ:<a href='https://seekingalpha.com/symbol/MRVL' title='Marvell Technology Group, Ltd.'>MRVL</a>) Cavium (CAVM) <a href=\"https://seekingalpha.com/pr/17204136-marvell-technology-group-ltd-announces-receipt-chinese-regulatory-approval-cavium-acquisition\" target=\"_blank\">merger</a> receives approval from Chinese regulators.</li><li>               Marvell expects the merger to close next month.&nbsp;</li><li>               Marvell shares are&nbsp;<font color='green'>up 11.8%</font>&nbsp;premarket to $22.50.&nbsp;&nbsp;</li><li>        Cavium shares are&nbsp;<font color='green'>up 5.7%</font>&nbsp;to $84.&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3366798\" data-linked=\"Marvell +11.8% on Chinese approval for Cavium deal\" data-tweet=\"$MRVL - Marvell +11.8% on Chinese approval for Cavium deal https://seekingalpha.com/news/3366798-marvellplus-11_8-on-chinese-approval-for-cavium-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3366798-marvellplus-11_8-on-chinese-approval-for-cavium-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}